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Escherichia coli senses a variety of chemoeffectors.  The Tsr chemoreceptor is 
known to mediate attractant response to serine.  Previously, serine was the only attract-
ant described for Tsr.  Recent work suggests Tsr senses Autoinducer-2 as an attractant 
via a periplasmic binding protein.  Autoinducer-2 is a general quorum sensing molecule 
recognized by Gram positive and Gram negative bacteria.  In E. coli it is bound to LsrB 
during AI-2 uptake. 
A testable model, based on the described interaction between MBP and the Tar 
chemoreceptor in E. coli, was generated.  I first hypothesized that the shoulder regions of 
Tsr would associate with areas of both the amino and carboxyl domains of LsrB to elicit 
chemotaxis to AI-2.  To test this, alanine-scanning mutations were generated in both Tsr 
and LsrB.  Results suggest AI-2 is sensed through a direct interaction between Tsr and 
LsrB.  I conclude residues Lys-147 and Glu-150 of Tsr and Asp-59, Asp-63 and Arg-252 
of LsrB are critical for AI-2 chemotaxis. 
I investigated the relationship between LsrB expression and AI-2 chemotaxis.  I 
hypothesized altering expression of LsrB relative to chromosomal level would affect AI-
2 chemotaxis.  This was tested by growing cells to late phase, increasing LsrB present, 
and by inducing plasmid-borne LsrB.  The results suggest increasing the LsrB present 
decreases AI-2 chemotaxis, though a clear conclusion cannot be drawn.  I also explored 
the effect making lsr deletions would have on LsrB expression and AI-2 chemotaxis.  I 
conclude there is little effect on AI-2 chemotaxis in these mutants.  Lastly, I hypothe-
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sized serine and AI-2 affect signaling to each other.  This was tested by using Tsr vari-
ants deficient for serine chemotaxis to test AI-2 chemotaxis to establish that recognition 
of serine and AI-2 occurs independently at separate locations on Tsr.  I introduced one 
ligand during log phase growth and tested chemotaxis response to the other ligand.  Re-
sults indicate that serine and AI-2 bind at separate sites.  However, AI-2 chemotaxis de-
creased when serine was present, though not vice versa.  I conclude the response to ser-
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Aer Cytoplasmic redox potential receptor 
AI-2 Autoinducer-2 
AS Amphipathic sequence of chemoreceptor 
ATP Adenosine 5’-triphosphate 
CB Chemotaxis buffer 
DNA Deoxyribonucleic acid 
DPD 4,5-dihydroxy-2,3-pentanedione 
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
KD Equilibrium dissociation constant 
kDa Kilodalton 
LB Luria Bertani broth 
LsrB Periplasmic binding protein for AI-2 uptake 
M Molar 
MBP Maltose binding protein 







PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
PDB Protein Data Bank 
R-THMF (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran 
SDS Sodium dodecyl sulfate 
Ser Serine 
Tap Transmembrane peptide/thymine receptor 
Tar Transmembrane aspartate receptor 
TB Tryptone broth 
TM1 Transmembrane helix one of chemoreceptor 
TM2 Transmembrane helix two of chemoreceptor 
Trg Transmembrane ribose and galactose receptor 
Tsr Transmembrane serine receptor µL Microliters µM Micromolar µg Microgram 
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CHAPTER I  
INTRODUCTION 
 
Escherichia coli motility and environmental stimuli 
Escherichia coli is a gram-negative bacterium of the family Enterobacteriaceae.  
It is rod-shaped and flagellated, measuring 2-4 µm in length and 0.7 µm in width.  Its 
motility in liquid or semi-solid media is achieved through the use of 4-8 peritrichous fla-
gella.  When these flagella rotate counterclockwise, the flagellar filaments form a left-
handed helical bundle that propels the cell forward in a run of several seconds (1).  This 
run can be at speeds of up to ten times the cell body length per second (40µm/s), and ei-
ther cell pole can act as leader (2).  Cells switch from run to a very brief tumble when 
clockwise rotation of the flagella results in a chaotic, rapid reorientation of the cell due 
to dissociation of the flagellar bundle (1).  Alternating between longer runs and shorter 
tumbles results in a three-dimensional random walk in a liquid environment (3). 
The cell can modulate this run/tumble bias to respond to favorable or unfavorable 
environmental stimuli.  Clockwise rotation of the flagellar motors is suppressed when a 
cell responds and moves to a favorable stimulus, allowing for a longer run in the direc-
tion of that stimulus, biasing the random walk when an attractant is present.  In short, 
this biased random walk is comprised of the net movement up or down the attractant or 
repellent gradient (3) (Figure 1).  Responding to these gradients of attractant or repellent 






Figure 1.  E. coli chemotaxis in an attractant gradient.  Counter-clockwise flagellar rota-
tion results in flagellar filaments forming a left-handed helical bundle, resulting in a run.  
Rotation clockwise dissociates the bundle and causes tumbling. Cell swims in a relative-
ly straight-line run, interrupted by brief three-dimensional reorienting tumbles.  This re-
sults in a biased three-dimensional random walk, as the cell suppresses the probability of 






Four transmembrane methyl-accepting chemotaxis proteins (MCPs) are present 
in E. coli to mediate chemotaxis.  These MCPs are located in polar clusters, typically in 
a large subpolar patch (2).  They are named based on the molecules for which they are 
responsible for mediating response:  taxis to L-serine and away from particular repellents 
(Tsr); taxis to L-aspartate and away from particular repellents (Tar); taxis to ribose and 
galactose (Trg); and taxis-associated protein for dipeptides (Tap) (4-10).  A fifth recep-
tor, Aer, mediates redox chemotaxis but does so in a methylation-independent manner 
(11-13).  Serine and aspartate are the only substrates shown to bind directly to their spe-
cific chemoreceptors (14, 15).  The other known substrates – maltose, ribose, galactose, 
glucose and dipeptides – require an initial binding to their respective periplasmic binding 
proteins before interacting with their specific MCPs.  Additionally, some molecules are 
sensed as repellents by two of these chemoreceptors.  Tsr senses both indole and L-
leucine as repellents, while Tar senses nickel (Ni2+) and some divalent cations such as 
cobalt (Co2+) as repellents (6, 14, 16, 17). 
 
Structure and function of E. coli chemoreceptors 
 Chemoreceptors exist in oligomeric units.  Single receptor homodimers form tri-
mers of dimers in the absence of other chemotaxis proteins, though these assemblies are 
stabilized by the scaffolding and kinase proteins at their cytoplasmic domain (18-21).  
These self-associated trimers of dimers localize to the poles of the cell in arrays (22-26) 
(Figure 2).  These clusters contain at least a few of all four of the described chemorecep-





Figure 2.  A patch of chemoreceptors embedded in the polar cell membrane.  (a) An il-
lustration depicting one lattice unit of chemoreceptors.  The receptors are represented by 
blue circles, and are arranged in trimers of dimers.  The CheA and CheW proteins are 
shown as red and purple rectangles, respectively.  The P3 domain of CheA is represented 
by green cirlces.  (b) An illustrated top view of a chemoreceptor array to show the hex-
agonal lattice.  The cartoon illustrates the proposed assembly of an extended chemore-
ceptor array.  CheA subunits P3 and P5, along with CheW are labeled in conjunction 
with the receptors to illustrate a core complex.  Three core complexes are interconnected 
by CheA/CheW interactions to form a single lattice unit, which assembles further into 





suggested by their close association in the receptor lattice (28-30).  This is further sup-
ported by the finding that bound ligand can induce an amplified effect on signaling in 
receptor patches, up to 35 times more than expected of individual receptors alone (31).   
Some attractants can be sensed by E. coli at the sub-micromolar concentration level, and 
gradients can be sensed over five orders of magnitude (32, 33). 
The amounts of Tsr and Tar, considered the major chemoreceptors, are present in 
approximately 3-5 fold greater abundance than Trg, Tap and Aer (34).  The major chem-
oreceptors do not require the presence of another receptor in order to perform chemotax-
is.  This is not true of the minor chemoreceptors.  Trg, Tap and Aer cannot perform 
chemotaxis alone, and each requires the presence of at least one of the major transducers 
before they can do so.  Additionally, there is no requirement that a major chemoreceptor 
ligand be present as a prerequisite for the minor transducers to perform chemotaxis to 
their respective ligands (35, 36).  These synergistic interactions serve to increase the sen-
sitivity of the system with regard to chemoeffector concentrations (37). 
Each of the five separate functional domains of Tsr and Tar carries out a particu-
lar function (38, 39) (Figure 3).  Ligands or binding proteins are sensed by the periplas-
mic domain, a four helix bundle (α1-4).  In the studied cases, small molecule ligands 
bind at the interface of the two subunits while binding protein-ligand complexes bind 
across the apex of the dimer, interacting asymmetrically with both subunits (40-42).  
Based on recent work, the AI-2 binding protein LsrB is predicted to do the latter (43). 
The transmembrane domain of the receptor is comprised of transmembrane helix 





Figure 3.  The functional domains of the chemoreceptor.  The schematic illustration 
shows three-dimensional organization of the domains in relation to the receptor dimer in 
the cell membrane.  Domains are distinct based on color and labeled in the center, and 





transducing a signal across the cellular membrane.  TM1 anchors the receptor in the 
membrane and stabilizes the homodimer.  Bound ligand signals are transduced by TM2 
across the membrane and into the cytoplasm.  TM2 is directly linked to the receptor’s 
cytoplasmic region by a Histidine kinase, Adenylate cyclase, Methyl-accepting chemo-
taxis proteins, Phosphatase (HAMP) domain. 
The HAMP domain exists as a four helix bundle.  Each of the dimeric subunits 
consists of parallel, alpha helical amphipathic sequences (AS1 and AS2).  Each dimer is 
connected by a flexible linker of fourteen residues (44-47).  The cytoplasmic domain, an 
extended four helix coiled coil, is adjacent to the HAMP domain and consists of the di-
meric adaptation and signaling domains, located just downstream of HAMP. 
Spatial chemical gradients and the changes in chemoeffector concentrations can 
be recorded through a sensory adaptation system governed by reversible covalent modi-
fications.  Four to six glutamyl residues in this adaptation region can be methylated by 
the chemoreceptor-specific CheR methyltransferase or demethylated by the CheB meth-
ylesterase.  These adaptation enzymes continuously maintain the methylation record 
through both phosphorylation of CheB by CheA, and through conformational changes 
that alter the propensities for methylation or demethylation.  In other words, when an 
attractant is bound, methylation propensity is high, while demethylation is low; the op-
posite is true for unbound kinase-active receptors (48-50).  This allows the cell to main-
tain a memory of its surroundings, particularly in regard to the chemoeffector gradient in 
which it may find itself.  This is very useful in dynamic environments such as the human 
gastrointestinal (GI) tract. 
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A two-component phosphorelay pathway governs receptor activity and ultimate-
ly flagellar rotation.  Prior to ligand-binding at its periplasmic domain, a chemoreceptor 
exists in a kinase-activating state that initiates a phosphorelay to the flagellar motors.  At 
the distal tip of the kinase control domain’s four helix bundle, are bound the kinase 
CheA and the scaffolding protein CheW.  These Che proteins are necessary for the re-
ceptors to cluster in their polar patches (48, 49, 51). 
The CheA histidine kinase, when bound to a chemoreceptor, is activated several 
hundred fold in the absence of chemoeffector gradients (52, 53).  CheA uses ATP to au-
tophosphorylate at a highly conserved His48 residue (54).  This phosphate group can 
then be transferred to the Asp57 residue of the CheY response regulator protein, allow-
ing CheY-P to bind with high affinity to the flagellar basal body, specifically the FliM 
motor protein (55-57).  Upon sufficient CheY-P binding, one or more flagella will rotate 
clockwise (CW), leading to the characteristic tumble of the cell (58-61).  Another sub-
strate for CheA-P is the methylesterase CheB.  Upon phosphorylation CheB-P will set 
about removing methyl groups from specific glutamyl residues of the adaptation domain 
involved in sensory adaptation (62). 
 
Stimulus input and signal transduction across the membrane 
At the periplasmic domain of the chemoreceptor, the input stimulus is first rec-
ognized.  Direct ligand-binding, as in the case of L-aspartate with Tar or L-serine with 
Tsr, occurs at one of two rotationally symmetric sites at the homodimer interface.  Sub-
sequently, the chemoreceptor displays negative half-of-the-sites cooperativity to an ex-
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treme degree, preventing a second, identical ligand molecule from entering and binding 
at the second site (63).  Along with adaptive methylation, this negative cooperativity 
aides the receptors in returning to their pre-ligand bound signaling state during chemo-
taxis. 
Ligand binding induces a conformational change of the chemoreceptor to the ef-
fect of a 20-degree rotation along the helical axes of the subunits, breaking the rotational 
symmetry of the homodimer (64, 65).  This results in a slight downward displacement of 
helix 4, purportedly propagating the signal through TM2.  This propagation through the 
transmembrane domain is not fully determined, but crosslinking studies with Tar suggest 
that attractant binding causes a piston-like, approximately 1.6 Ångstrom displacement of 
TM2 toward the HAMP domain, while methylation displaces it toward the periplasm in 
a return to the pre-ligand binding state (66-68). 
Signal transduction passes through the transmembrane region and into the 
HAMP domain, where conformational changes link attractant binding at the periplasmic 
domain to kinase activity at the cytoplasmic domain.  Here the evidence suggests that 
changes in stability of the four helix HAMP bundle are generated by helical sliding of 
TM2, which in turn modulates destabilization between AS2 of HAMP and the kinase-
control region (69).  Additional mutational and biochemical studies suggest that signal 
transduction is mediated through anti-symmetrical changes in helix-helix packing in the 
adaptation and cytoplasmic domains (70, 71).  According to this predicted model, at-
tractant binding information stabilizes the HAMP four helix bundle, thereby destabiliz-
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ing the cytoplasmic domain and kinase control module, effectively turning off the ki-
nase. 
When an attractant binds at the periplasmic receptor domain, CheA autophos-
phorylation activity is inhibited, reducing the amount of CheY-P present in the cyto-
plasm, inducing counter-clockwise (CCW) flagellar rotation.  The reduction of CheY-P 
is further enhanced through the activity of CheZ, a phosphatase that targets CheY-P, al-
lowing the cell to quickly reduce its CheY-P levels in response to attractant binding.  
Bundles of CCW rotating flagella propel the cell in its characteristic run (72-76). 
The receptors can be reset to a pre-stimulus state following attractant binding.  
This is achieved through methylation and demethylation of specific glutamyl residues 
that serve as substrates for the CheR (methyltransferase) and CheB (methylesterase) pro-
teins that carry out adaptive methylation (77).  These enzymes bind to the NWETF pen-
tapeptide at the carboxyl terminus of the major chemoreceptors (Tsr and Tar).  The glu-
tamyl residues within the adaptation domain are reached due to a flexible coupling of the 
pentapeptide to the four helix bundle.  The minor chemoreceptors (Trg and Tap) lack the 
pentapeptide at their carboxyl terminus, relying primarily on CheR and CheB enzymes 
bound to Tsr and Tar within the mixed receptor patch to undergo adaptive methylation 
(77).  Adaptation enzymes interacting with one receptor can modify sites equivalent to 
those on approximately 6 neighboring dimers (78).  The flexible tether of the receptor 
that binds CheR and CheB has been shown in molecular models to allow CheR to physi-
cally reach at least a few modification sites on eight of the neighboring receptors, indi-
cating so-called assistance neighborhoods for adaptation response (79).  Adaptive meth-
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ylation serves to convey an environmental memory to the cells, allowing them to sense 
dynamic changes in their surroundings.  This is achieved in part because the kinetic rates 
of the enzymes responsible for adaptation are slower than the time-scale of chemoeffec-
tor binding, allowing the cells to compare current ligand occupancy at the periplasmic 
binding sites with methylation of the glutamyl residues resulting from previous ligand 
binding (39, 80).  This serves as the basis for a chemotaxis response.  A more complete 
view of the signaling cascade and adaptation is represented in Figure 4.  
 
Quorum sensing and Autoinducer-2 
 Population density is a key factor in regulating various functions in bacteria, in-
cluding control of pathogenesis and recruitment to and maintenance of biofilms (81, 82).  
Quorum sensing is the means by which bacteria can assess population density, and it re-
lies on the recognition and determination of autoinducers (AIs).  These compounds in-
crease proportionally with population density, diffusing back into the cell upon reaching 
a certain concentration threshold, mediating the quorum sensing response.  Some genes 
are induced by AIs, namely those that are involved in that specific AI’s production, cre-
ating a positive feedback loop.  Typically, the cell density must reach 108 cells per mL or 
higher in order to trigger AI effects on the population. 
Quorum sensing through AIs also allows bacteria to communicate both in an in-
tra- and interspecies manner.  General autoinducer synthesis genes have been found in 
approximately half of the sequenced bacterial genomes (81, 83).  While it was previous-





Figure 4.  The chemoreceptor signaling cascade.  Left receptor shows cascade effects 
following attractant ligand binding (red theme).  CheA kinase is not phosphorylated, 
thus the phosphorelay of signal to the flagellar motor does not occur.  Right receptor 
shows effects in the absence of attractant ligand (black theme).   Inactive components are 
shown in white with color outline.  Solid lines denote enzymatic reactions, while dashed 
lines denote binding interactions.  Adaptation sites are shown as methylated (black cir-




aspect of autoinducer production, as evidenced by the species specificity of particular 
AIs, newer studies have indicated cross talk between different species or genera of bac-
teria is equally important and can be achieved through the use of general AIs (84, 85).  
Current knowledge indicates bacteria can integrate signals from their environments to 
determine if the AI being sensed comes from itself, from other microbes present, or from 
human stress hormones (86).  This ability would be particularly useful in the human GI 
tract. 
 Species-specific autoinducers (AI-1s) in Gram-negative bacteria are acyl ho-
moserine lactones and modified peptides in Gram-positive bacteria.  A separate class of 
AI is more generally recognized across many Gram-negative and Gram-positive species.  
Autoinducer-2 is an example of a general AI, and is used in conjunction with species-
specific AIs in certain bacteria.  For example, the marine bacterium Vibrio harveyi re-
quires the presence of both a specific AI-1 and AI-2 to fully induce bioluminescence 
(87).  This bioluminescence study was the first in which AI-2 was identified. 
 Following its identification, AI-2 and its synthase enzyme LuxS have been found 
to be widely distributed in different bacteria across the kingdom Eubacteria (83, 84, 88).  
This discovery helped shape the prediction that AI-2 is used for interspecies communica-
tion.  AI-2 is synthesized by LuxS, a homodimeric Fe2+ metalloenzyme involved in the 
activated methyl cycle of bacteria (89-91).  In this cycle, S-adenosylmethionine (SAM) 
is converted back to homocysteine, through an S-adenosylhomocysteine (SAH) interme-
diate, although it can also be converted to 4,5-dihydroxy-2,3-pentanedione (DPD) from 
S-adenosylribosylhomocysteine (SRH) by LuxS cleavage (84, 92, 93).  This DPD mole-
 14 
 
cule is highly unstable and quickly converted to a precursor for AI-2 (93).  Both the acti-
vated methyl cycle and DPD cyclization pathway are shown in Figure 5.  This DPD bio-
synthetic pathway in Vibrio harveyi has been shown to be identical for many bacteria, 
including E. coli (92, 93). 
 Once the structure of AI-2 was determined through co-crystallization studies in 
Vibrio harveyi, it was determined that a borated DPD spontaneously cyclizes to form a 
furanosyl borate diester AI-2 compound, binding to its cognate receptor LuxP (94).  A 
similar investigative approach was used in Salmonella to co-crystallize AI-2 with its 
cognate receptor, the Lsr (LuxS-regulated) binding protein, a product of the Lsr operon.   
The co-crystallization with its binding protein also revealed that Salmonella recognizes 
the chemically distinct, non-borated (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF) form of AI-2 (95).  Both the borated and non-
borated forms exist in equilibrium with each other, though this can be influenced by the 
addition or removal of borate (81, 94). 
 
The Lsr operon and its role in AI-2 uptake and chemotaxis 
In Salmonella enterica serovar Typhimurium, AI-2 concentration is regulated by 
the seven Lsr operon gene products, including an ATP-binding cassette (ABC) trans-
porter and AI-2 degradation proteins (96).  In this system, AI-2 serves as a transcription-
al activator, relieving LsrR repression of the lsrACDBFGE operon.  This increases ex-
pression of the AI-2 transport apparatus:  ABC transporter proteins LsrA, LsrC and 





Figure 5.  The synthesis pathways for DPD and AI-2.  (a) The activated methyl cycle 
involves cleavage of S-ribosylhomocysteine (SRH) into homocysteine or dihydroxypen-
tanedione (DPD), the precursor for AI-2.  (b) DPD is highly unstable and spontaneously 
cyclizes in the presence of borate into borated and non-borated isomers that exist in 




lation occurs during mid to late exponential growth and declines rapidly at the onset of 
stationary phase as a result of its import through the transporter into the cytoplasm (97).  
The lsrF, lsrG and lsrE genes are required for processing and turnover of AI-2 once it 
reaches the cytoplasm (96).  Two adjacent, but separately transcribed genes are lsrR and 
lsrK.  The kinase product of lsrK phosphorylates internalized AI-2, and it is this AI-2-P 
that de-represses the LsrR repressor and activates transcription of the other lsr genes 
(Figure 6a) (96). 
E. coli possesses a homologous lsr operon, the b1513 operon (Figure 6b), encod-
ing homologous genes and functions (98).  Because of this homology, the lsr operon 
nomenclature will be used henceforth to describe E. coli genes and gene products per-
taining to the b1513 operon.  The transport channel for AI-2 uptake is composed of 
LsrA, LsrC and LsrD and is located in the cytoplasmic membrane.  Translated with a 
leader peptide, LsrB is exported to the periplasm via the Sec system.  Here it is free to 
bind the extracellular AI-2 that remains in the periplasm following its export from the 
cell mostly via the TqsA protein (99).  The remaining AI-2 molecules diffuse through 
outer membrane pores and accumulate externally, re-entering the periplasm via equili-
bration with the external environmental AI-2 when it reaches a concentration threshold. 
Recent studies with AI-2 in E. coli revealed that only the R-THMF form is rec-
ognized as an attractant that stimulates chemotaxis, requiring both the Tsr chemorecep-
tor and the binding protein gene product of the Lsr operon, LsrB (43, 100).  E. coli LsrB 
closely resembles Salmonella LsrB (Figure 7), to an 85% sequence identity (101).  When 





Figure 6.  The Salmonella lsr operon and its homolog in E. coli.  (a) The lsr locus in 
Salmonella.  Transcription units are separated by black promoter boxes, and black ar-
rows indicate direction of transcription for each unit.  The small dark blue pentagons 
represent AI-2, which is made by LuxS and exported from the cell via the TqsA trans-
porter (not shown).  The Lsr ABC transporter reimports AI-2 into the cytoplasm, where 
it is phosphorylated by the LsrK kinase using ATP.  Phosphorylated AI-2 relieves re-
pression by LsrR, allowing expression of the lsrACDBFGE operon.  LsrF and LsrG de-
grade AI-2-P.  The function of LsrE is not clear, and it is absent in E. coli.  (b) The 
b1513 operon of E. coli is a homolog of the Salmonella lsr operon.  The E. coli gene 
designations are given inside the arrows, and the Salmonella homologs are listed beneath 










Figure 7.  Salmonella LsrB crystal structure.  The cartoon depicts the crystal structure of 
Salmonella LsrB in complex with the R-THMF isomer of AI-2.  The amino and carboxyl 
terminals are labeled, as is the AI-2 ligand.  The two subunits are asymmetrical, entering 
the closed conformation only when AI-2 is bound.  E. coli LsrB is 85% identical to Sal-
monella LsrB, with only a few amino acid residue differences, and the AI-2 binding sites 
are identical.  Only the R-THMF isomer of AI-2 binds in such a manner to elicit an at-
tractant chemotaxis response in E. coli.  Deletion of LsrB abolishes chemotaxis to AI-2 





Figure 8.  Proposed AI-2 chemotaxis pathway in E. coli.  The R-THMF isomer of AI-2 is 
shown to the left (not to scale).  The figure to the right shows the proposed pathway by 
which E. coli cells sense and respond to AI-2 (red pentagons) as a chemoattractant.  The 
ABC transporter product of the lsr operon is shown in the cell membrane.  AI-2-bound 
LsrB binds to the channel during AI-2 uptake as previously reported (98).  Also present 
in the membrane is the Tsr chemoreceptor, complete with chemotaxis proteins for alter-
ing flagellar rotation.  This model proposes that LsrB can interact with the Tsr receptor 
to elicit an attractant response, inhibiting phosphorylation along the phosphorelay path-





Conversely, deletion of the ABC transporter components of the lsr operon does not neg-
atively affect AI-2 chemotaxis, suggesting that uptake of AI-2 to the cytoplasm is not 
necessary for chemotaxis to occur (43).  Only deletion of Tsr was shown to abolish AI-2 
chemotaxis (43).  Thus, the study concluded that (i) both Tsr and LsrB were necessary 
for E. coli to perform chemotaxis to AI-2; and (ii) uptake into the cell is not required to 
elicit an attractant response.  It was hypothesized, based on this information, that AI-2-
bound LsrB in the periplasm likely interacts with the periplasmic domain of Tsr to pro-
duce a chemotactic signal (Figure 8). 
 
Dissertation overview 
 Previous work in the field of chemotaxis had never identified a binding protein 
interaction with the Tsr chemoreceptor.  Only recently has a binding protein interaction 
for Tsr been discovered, although the details surrounding this interaction remained un-
clear (43).  The research undertaken and presented in this dissertation examines the in-
teraction between Tsr and the AI-2-bound LsrB binding protein during AI-2 chemotaxis. 
 Chapter II describes my research in altering residues at the predicted interaction 
sites between Tsr and LsrB.  The hypothesis was that individually altering select resi-
dues on both proteins would disrupt chemotaxis to AI-2 and give a better picture of the 
binding interaction and the critical residues involved in stabilizing the interaction to al-
low for signaling.  The results suggest that the Lys-147 residue on the periplasmic 
shoulder regions of the Tsr homodimer are critical for AI-2 chemotaxis to occur.  The 
results also suggest several residues in both the N-terminal and C-terminal domains of 
the LsrB monomer are important for this chemotaxis response, with Asp-59 in particular 
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showing a dominant negative phenotype for AI-2 chemotaxis when altered.  All of the 
mutations generated were checked to make sure that that particular mutation did not pre-
vent expression of the protein in an attempt to avoid false conclusions. 
 In Chapter III, my research attempted to correlate chemotaxis to AI-2 with vari-
ous levels of LsrB expression.  Plasmid-borne LsrB was induced with varying concentra-
tions of IPTG to increase the amounts of the protein present in the cell during chemotax-
is.  It was determined that only about 23-25 copies of LsrB exists per cell under normal 
conditions, and that increasing the amount of LsrB present via induction drastically re-
duced chemotaxis to AI-2.  Non-polar deletion mutants of the lsr operon were also used 
in attempt to determine how its components affect LsrB expression levels in vivo, and 
how these levels correspond to AI-2 chemotaxis. 
Chapter IV describes my efforts in determining if (a) mutating residues crucial 
for the serine binding pocket also alter response to AI-2, and (b) if serine and AI-2 alter 
response to one another when the other is present at high concentrations.  First, mutants 
for serine chemotaxis were exposed to a gradient of AI-2 and their response was deter-
mined.  Results showed a lack of response to serine, but unimpaired response to AI-2.  
Additionally, mutations from Chapter II that reduced or abolished chemotaxis to AI-2 
did not affect response to serine in those mutants.  Second, exposing cells to high con-
centrations of one chemoeffector, then running chemotaxis assays to detect response to 
the other chemoeffector, gave an idea of the effect of the presence of one ligand on the 
other.  Chapter V summarizes the experiments and discussion from my research and 
proposes future directions and experiments for this investigation. 
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CHAPTER II  




 Population density regulates many physiological activities and responses in bac-
teria, including formation of biofilms and expression of virulence factors.  This regula-
tion is accomplished through the use of quorum-sensing molecules that accumulate as 
population density increases.  Autoinducer-2 (AI-2) is a general quorum-sensing mole-
cule produced and secreted by numerous Gram-positive and Gram-negative bacteria.  It 
is derived from the ribose moiety of S-adenosylhomocysteine following that molecule’s 
conversion of that to S-ribosylhomocysteine and subsequent cleavage by the LuxS en-
zyme into 4,5-dihydroxy-2,3-pentanedione (DPD).  The unstable, linear DPD molecule 
spontaneously cyclizes into either (2S,4S)-2-methyl-2,3,3,4-
tetrayhydroxytetrahydrofuran borate (S-THMF borate) or (2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R-THMF). 
 S-THMF borate regulates bioluminescence and virulence in Vibrio species, in-
cluding Vibrio harveyi.  A periplasmic binding protein of Vibrio, LuxP, binds this borat-
ed form of AI-2 with high affinity (KD of <1 µM) (102, 103).  The R-THMF isomer of 
AI-2 is reported to bind to the LsrB periplasmic binding protein of Salmonella, E. coli 
and other enteric bacteria with an apparent KD of 160 µM (103).  This reported binding 
affinity for R-THMF AI-2 to LsrB is somewhat conjectural, due to the extreme instabil-
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ity of AI-2 in solution, and the equilibrium between the two naturally occurring THMF 
isomers. 
 AI-2 is synthesized by LuxS and secreted into the periplasmic space, partly by 
the activity of TqsA efflux transport.  Once in the periplasm, it can passively diffuse into 
the external environment to be sensed by neighboring cells.  The ability of cells to take 
up AI-2 relies on the products of the lsr operon.  The LsrB periplasmic binding protein 
binds AI-2 and interacts with an ABC transporter composed of a heterodimer of the two 
membrane-spanning LsrCD proteins and the cytoplasmic kinase LsrA. 
The LsrK kinase phosphorylates the DPD intermediate of AI-2, creating phos-
pho-DPD (DPD-P).  This phosphorylated molecule binds the repressor of the lsr operon, 
LsrR, relieving repression and inducing transcription of lsrACDBFG.  Two downstream 
gene products in this operon, LsrF and LsrG, degrade DPD-P, completing the regulatory 
cycle of AI-2 uptake and processing.  This is an unconventional cycle, as AI-2 induces 
expression of factors needed both for its uptake and those required for its destruction. 
 Recently, it was shown that AI-2 is a potent chemoattractant for E. coli strain 
RP437, requiring the activity of both the LsrB periplasmic binding protein and the Tsr 
chemoreceptor (43).  Import of AI-2 into the cytoplasm is not required for its being 
sensed as an attractant.  A mutant lacking the ABC transporter protein LsrC was still 
able to perform normal chemotaxis to AI-2.  Because of this finding, it was proposed 
that AI-2-bound LsrB interacts directly with the periplasmic domain of the Tsr chemore-
ceptor dimer.  There is precedent for this type of interaction between binding protein and 
chemoreceptor, as evidenced with the E. coli aspartate receptor (Tar) and maltose bind-
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ing protein (MBP) (104, 105).  Periplasmic maltose must first bind to MBP, causing a 
conformational shift of MBP that can interact with Tar.  Maltose-loaded MBP interacts 
with both subunits across the Tar dimer, involving certain residues on the surfaces of 
MBP and Tar (104, 106).  This is also true of ribose and galactose binding proteins with 
Trg and DppA with Tap (5,7,8,10). 
 Based on the published Tar-MBP interaction, a computerized docking simulation 
was performed of the x-ray crystallographic structure of Salmonella LsrB, in its ligand-
bound conformation (95), with the x-ray crystallographic structure of the ligand-free 
periplasmic domain of E.coli Tsr (107).  In the Tar-MBP model, the ligand-free Tar was 
oriented to the most likely fit of MBP using SPOCK software (108, 109), then refined 
based on the experimental data. 
Likewise, the Tsr-LsrB simulation was carried out using this software to obtain a 
testable model.  Next, site-directed alanine scanning mutagenesis was used to probe the 
amino acid residues predicted to be at the sites of interaction between the two proteins.  
Tsr variants generated retained wild-type function for serine chemotaxis, and LsrB mu-
tant proteins remained stable, and maybe functional for AI-2 uptake.  The binding site 
for R-THMF was not affected by these residue changes. 
The results reported here support the computer docking model for the LsrB-Tsr 
interaction and identify residues on both proteins that are critical for their interaction 
during binding and signaling, ostensibly without affecting the ability of LsrB to carry out 




Materials and methods 
 Bacterial strains, plasmids and media.  Strain CV1, equivalent to strain RP437 
(110), was used as the wild-type E. coli strain for chemotaxis.  All relevant strains and 
plasmids are listed in Table 1.  Plasmids pCA24N was used to express the wild-type and 
mutant Tsr and LsrB proteins at near-chromosomal levels.  Additionally, plasmid 
pBAD18 was used to express lsrB from the arabinose-inducible pBAD promoter (111).  
Mutations were introduced into tsr and lsrB using the standard protocol for site-directed 
mutagenesis (Stratagene).  Tryptone broth (TB; 10 g/L tryptone and 8 g/L NaCl) was 
used to culture cells at 30°C for all assays (112).  Chemotaxis buffer (CB; 1X phosphate-
buffered saline, 0.1 mM EDTA, 0.01 mM L-methionine and 10 mM DL-lactate) was 
used to wash cells and deliver attractants.  AB medium contained 2 g/L casamino acids, 
12.3 g/L magnesium sulfate heptahydrate, 17.5 g/L NaCl, 1 mM L-arginine, 1 % v/v 
glycerol and 10 mM potassium phosphate buffer, pH 7.0 (113).  Chemically synthesized 
DPD (114) (17.57 mM) was purchased from the research group of Rita Ventura at the 
Insituto de Tecnologia Química e Biológica (ITQB-UNL) in Oeiras, Portugal.  L-serine 
was purchased from Fisher Scientific (Fairlawn, NJ).  Vibrio harveyi TL26 was a kind 
gift from Bonnie Bassler, Princeton University. 
Measuring chemotaxis to attractants.  Capillary assays, first developed by Adler 
et al. (115) were used to quantify the response to AI-2.  Overnight cultures of cells ex-
pressing Tsr or LsrB mutant proteins from pCA24N were grown at 30°C in TB supple-
mented with streptomycin (50 µg/mL) and chloramphenicol (35 µg/mL).  Cultures were 
back-diluted to a turbidity of ~0.050 at O.D.600 in 25 mL TB without antibiotic and then 
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Table 1.  Bacterial strains and plasmids 
Strain or plasmid Genotype Resistancea Source 
    
Escherichia coli    
    
CV1 Wild-type chemotaxis Strep (110) 
    
CV5 CV1 ∆tsr Strep (43)b 
    
AS2002 CV5 +pCA24N-tsr Strep/Cm This studyc 
    
CV1 (ΔlsrB) ∆lsrB Strep This studyd 
    
AS2014 CV1 ∆lsrB/luxS Strep This studye 
    
Vibrio harveyi    
    
TL26 ∆luxN/∆luxS/∆cqsS  (116)f 
    
Plasmids    




    
pCA24N-tsr pCA24N PT5-lac::tsr Cm (118) 
    
pCA24N-lsrB pCA24N PT5-lac::lsrB Cm (118) 
    
pBAD-lsrB pBAD PBAD::lsrB Amp This studyh 
    
a Strep – streptomycin; Kan – kanamycin; Cm – chloramphenicol; Amp – ampicillin 
b Contains Δtsr9101 (119) introduced via phage transduction 
c Constructed by transforming strain CV5 with pCA24N-tsr 
d Constructed by removing Kan cassette (120) from MJ101(43) 
e Constructed by removing the kanamycin resistance cassette from lsrB in MJ101 using FLP recombinase.  
This removal was selected for through lack of growth on Kan media and PCR was used to verify its re-
moval.  Phage transduction was then used to add the kanamycin resistance cassette to disrupt luxS.  This 
was selected for through growth on Kan media and verified through PCR, then Kan cassette was removed 
using FLP recombinase. 
f Disrupted for sensing AHLs and CAI-1.  It senses only exogenously added AI-2. 
g This plasmid was transformed into MJ101 and selected for through Amp-resistance.  The recombinase 
recognizes flanking sites of the Kan-resistance cassette and removes it from the DNA.  The plasmid is then 
cured by growth at 43°C, restricting its temperature sensitive origin of replication.  The resulting strain is 
now both Kan- and Amp-sensitive. 





Figure 9.  The capillary assay.  Cell chamber ponds are created by placing a C-shaped 
plastic gasket onto a glass microscope slide, then adding a square, glass coverslip on top.  
Washed cells are loaded into the chamber to create the pond.  1 mm capillaries loaded 
with chemoeffector are inserted into the chamber pond and incubated for 45 minutes to 
allow diffusion and chemotaxis response.  Capillaries are then removed and their con-
tents expelled into dilution buffer for plating.  Overnight incubation of plates allows for 





grown to mid-logarithmic phase at an O.D.600 = ~0.500.  Expression of Tsr from AS2002 
was induced with 100 µM IPTG (121) at O.D.600 = ~0.300 and allowed to continue 
growth to ~0.500.  Expression of LsrB from AS2014 was not induced.  Cells expressing 
plasmid pBAD-lsrB were prepared similar to cells expressing pCA24N-lsrB with the 
exception that expression of pBAD-lsrB was induced with 0.2% L-arabinose at the time 
of back dilution from overnight culture.  Cell cultures of 5 mL were centrifuged at 600 x 
g for 10 minutes to separate the soft pellet from the growth media.  The pellet was gently 
resuspended in an equal volume of CB and incubated for fifteen minutes of recovery 
time in a 30°C rotor set to low speed.  The resuspended cells were used for the assay.  
Motility of the resuspended cells was confirmed through phase contrast microscopy. 
Capillary assays used plastic gaskets sandwiched between a glass microscope 
slide and glass coverslip to create the pond chamber (Figure 9).  About one sixth of the 
gasket was excised to provide an insertion point for both cells and capillaries into the 
chamber.  A 1 microliter volume capillary was flame-sealed at one end and lowered into 
a solution containing the desired concentration of attractant to be tested.  The CB-
buffered attractant was pulled several millimeters into the capillary. 
Capillaries contained either CB alone or CB supplemented with the different 
concentrations of L-serine or AI-2.  The cells were inserted into the chamber ponds via 
gentle pipetting to avoid bubbles or flagellar shearing.  Capillaries were then inserted 
through the opening of the chamber and cells were incubated at 30°C for 45 minutes.  
Diffusion of the chemoeffector from the open end of the capillary into the pond created a 
gradient that could be sensed by the cells (115).  These cells migrated up the gradient 
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and into the capillary mouth if the attractant signal was strong enough.  Once incubation 
finished, the capillaries were removed and their contents expelled into CB for dilution.  
Dilutions were plated on nutrient agar supplemented with appropriate antibiotic and al-
lowed to grow at 37°C overnight.  Colonies were counted and the number of cells that 
entered the capillaries was calculated.  All data was normalized to CB background. 
Computer generated docking model and residue selection.  The MBP-Tar model 
(122) was used as a guide to generate a computerized docking model for LsrB-Tsr.  
SPOCK software (108) was used to align amino acid residues on the surface of AI-2-
bound LsrB (95) (Protein Data Bank ID=1TJY) believed to be in contact with Tsr, based 
on the crystal structure for E. coli Tsr (107) (PDB ID=2D4U).  Also taken into account 
were unpublished findings that replacements at particular residues in LsrB altered chem-
otaxis to AI-2.  Care was taken to ensure these residues were oriented for close contact 
with Tsr.  Molecular dynamics calculations were done by using AMBER (123) software 
to simulate docking, following the removal of all overlap between the Tsr and LsrB 
structures.  A distance-dependent dielectric field, at an initial temperature of 300 Kelvin 
with a time step of 0.001 ps, was used to carry out all simulations, with the default force 
field suggested by the AMBER software. 
Site-directed mutagenesis of tsr and lsrB.  Point mutations were made in plasmid-
borne tsr and lsrB genes using a site-directed PCR mutagenesis protocol closely follow-
ing the protocol suggested by the Stratagene QuikChange™ II Site-Directed Mutagene-
sis Kit (Stratagene, La Jolla, CA).  Amino acid residues in α-helix 3-4 (Gly144-Glu150) 
of the subunit 1 and 1’ “shoulder” regions of the Tsr dimer were targeted and individual-
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ly changed to alanine or other residues using primers designed according to well estab-
lished principles for mutagenesis (124).  Amino acid residues Leu56-Pro65 of β-strand 
2, and Asp249-Glu256 of α-helix 8 of LsrB were targeted for individual replacement us-
ing the same guidelines. Primers were synthetic oligonucleotides (Integrated DNA 
Technologies™) containing the desired mutation, each complementary to opposite 
strands of the pCA24N-tsr, pCA24N-lsrB and pBAD-lsrB vectors.  These primers were 
extended by the Pfu Ultra DNA polymerase during temperature cycling over multiple 
PCR cycles.  Following PCR, the product is treated with the Dpn I endonuclease to elim-
inate methylated and hemi-methylated DNA (the parental template).  Because the tsr and 
lsrB genes cloned into pCA24N and pBAD18 were derived from E. coli, this Dpn I di-
gest selects for mutated synthesized DNA because plasmid DNA isolated from our E. 
coli strains is methylated.  Mutated tsr and lsrB genes were then subjected to multiple 
rounds of PCR sequencing to confirm that only the desired point mutations were present.  
Plasmids containing desired mutant genes were then transformed into their competent 
cells (CV1 ∆tsr for tsr and CV1 ∆lsrB for lsrB) and frozen. 
 Creation of the ∆lsrB/∆luxS strain AS2014.  Strain MJ101 (lsrBΩKanr) was 
transformed with pCP20 (FLP recombinase/Cmr) (117).  Transformants were allowed to 
grow at plasmid’s permissive temperature (30°C) to constitutively express FLP recom-
binase gene product.  FLP recombinase removes the kanamycin cassette during growth 
phase of transformants to leave a clean, non-polar deletion of the targeted gene, a result 
confirmed by failure of the transformants to grow on kanamycin media (50 µg/mL) dur-
ing replica plating.  Transformants were then grown at restrictive temperature of pCP20 
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(43°C) to cure the cells of the plasmid.  Plasmid curing was confirmed by replica plating 
cells onto media supplemented with chloramphenicol (35 µg/mL) and their subsequent 
failure to grow.  The resulting strain MJ101was now ∆lsrB (no Kan cassette). 
 P1 phage transduction was performed to transduce the kanamycin cassette from a 
CV1 (luxSΩKanr) strain to the ∆lsrB strain.  The transductants were grown on media 
supplemented with kanamycin (50 µg/mL).  Isolated transductants were subjected to 
PCR with primers for the kanamycin cassette gene, the lsrB gene and the luxS gene.  
Following PCR the products were run on a 1% agarose gel supplemented with ethidium 
bromide, then viewed under ultraviolet light to confirm insertion of the kanamycin cas-
sette and removal of the luxS gene.  Removal of the kanamycin cassette disrupting luxS 
was done as explained above.  Once these results were confirmed, strain AS2014 
(∆lsrB/∆luxS) was made competent and ready for use. 
 Immunoblot analysis for LsrB expression.  Overnight cultures of CV1 ∆lsrB con-
taining pCA24N expressing LsrB protein were diluted into 500 mL TB and grown at 
30°C with shaking to O.D.600 = 0.500.   Cultures were centrifuged and the pellet was fro-
zen at -80°C before resuspension in 25 mL lysis buffer (5 mM DTT, 50 mM Tris (pH 
8.0), 300 mM NaCl, 1 mM PMSF).  Resuspended pellets were then sonicated for 8 
minutes (15 seconds ON / 45 seconds OFF, 37% amplitude).  Centrifugation at ultra-
high speed followed before the supernatant was collected in lysis buffer.  This was then 
concentrated to 1 mL and quantified using the BCA assay.  PAGE was performed on 
these whole cell protein preps (20 µL/well) in the presence of 10 µg DTT on 10 % Mini-
PROTEAN TGX® Stain-Free™ Protein Gels (Bio-Rad).  The separated proteins were 
 32 
 
transferred onto a low-fluorescence PVDF membrane (Thermo-Fisher Scientific) at 100 
volts for 1 hr using the Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad).  The 
membrane was placed in blocking buffer (3% non-fat dry milk; 10 mM Tris pH 7.5, 100 
mM NaCl, 0.1% Tween 20 (TBST)) and incubated with agitation for 1 hour at room 
temperature. It was then transferred into primary antibody solution (1:2500 Protein A 
purified anti-LsrB antibody in blocking buffer) and incubated with agitation for 1 hr at 
room temperature, followed by thorough washing in TBST (3x, 5 mins each). The mem-
brane was then transferred into secondary antibody solution (1:25,000 anti-goat HRP 
(Sigma A5420) in blocking buffer) and incubated with agitation for 1 hr at room temper-
ature, followed by thorough washing in TBST (3x, 5 mins each). The membrane was 
developed with ClarityTM ECL Blotting Substrate (Bio-rad) and imaged using the Chem-
iDocTM Touch Imaging System (Bio-Rad). ImageLabTM software (Bio-rad) was used for 
total protein normalization and estimation of relative LsrB levels. 
 AI-2 uptake assays with Vibrio harveyi.  Overnight cultures of LsrB variants 
were diluted into 15 mL of TB at 30°C with shaking to O.D.600 = 0.500.  Cultures were 
then distributed into separate tubes, AI-2 was added, and the samples were incubated at 
30°C with shaking.  Samples were collected every 30 min for a total of 10 hrs.  Samples 
were centrifuged and the supernatants collected and frozen for use in the Vibrio harveyi 
TL26 bioluminescence assay.  This reporter strain is disrupted for signaling pathways for 
acyl-homoserine lactones (AHLs) and the alpha-hydroxyketone (CAI-1), as well as for 
synthesis of AI-2 (∆luxS); therefore, it responds only to exogenously added AI-2 and 
cannot produce AI-2 on its own.  TL26 was diluted 1:5000 and 90 µL was added to each 
 33 
 
reaction containing 10 µL of thawed samples.  Bioluminescence was then measured eve-
ry hour until the background began increasing.  Fold induction in luminescence was 
measured as Relative Light Units (RLU) of sample / RLU of medium. 
 Confirmation of LsrB variant response from a separate vector.  Because of the 
absence of tight control of the PT5-lac promoter in pCA24N, and a short C-termianl exten-
sion, key lsrB variants were constructed in an expression vector with tighter promoter 
control and no C-terminal extension.  Site-directed mutagenesis was utilized as de-
scribed previously to introduce point mutations D59A, V60A, T61A, D63A, R252A and 
E256A into pBAD-lsrB.  These mutant proteins were then expressed through addition of 
0.2% by volume L-arabinose to back diluted cultures growing at 30°C.  Capillary assays 
were performed as described previously to measure chemotaxis to AI-2 gradients. 
 
Results 
 Generation of the Tsr-LsrB docking model.  Using the SPOCK and AMBER 
software programs, the best predicted interaction between the periplasmic domain of Tsr 
and the AI-2-bound LsrB binding protein was determined.  This interaction and regions 
of interest are shown in Figure 10. 
Mutagenesis of tsr.  The effect of mutating individual residues from Gly144 to 
Glu150 to Ala in the “shoulder” regions of Tsr subunits 1 and 1’ was tested.  These ami-
no acid residues and their relative positions are shown highlighted in red in Figure 11.  






Figure 10.  The Tsr-LsrB docking model.  (a) The published docking model for the 
E.coli aspartate chemoreceptor (Tar) with ligand-bound maltose binding protein (MBP) 
(122).  The upper image shows the likely conformation the proteins adopt during interac-
tion.  MBP is shown in blue, with maltose bound at its center.  The periplasmic domain 
of Tar is colored by subunit.  The lower image shows the “tightness” of the Tar-MBP 
interaction.  Yellow arrows indicate critical binding sites.  (b) The proposed docking 
model for Tsr-LsrB based on the SPOCK and AMBER software employed (un-
published).  The upper image shows the likely interaction dynamics, while the lower im-
age speculates on the strength of the binding.  Yellow arrows indicate predicted critical 





Figure 11.  Tsr residues mutated based on docking model.  (a) The cartoon structure of 
the dimerized Tsr periplasmic domain is shown.  This model depicts the closed binding 
conformation of the receptor when serine is bound, and the monomeric subunits are de-
fined by color.  (b) The backbone structure taken from the image in (a) indicates amino 
acid residues predicted to be in closest contact with LsrB by highlighting them in red.  
This indicated portion extends from Gly144 to Glu150 of subunits 1 and 1’.  Individual 
residues were subjected to site-directed mutagenesis to alanine or other amino acids.  
The serine binding pocket is unaffected by these mutations.  Structures adapted from 





 Reviewing the components necessary for E. coli cells to mediate AI-2 chemotaxis.  
To quantify the AI-2 response and compare it to that of L-serine, capillary assays were 
performed (115).  CV1 and CV4 (∆tar) cells accumulated in capillaries containing either 
L-serine or AI-2.  Cells that were ∆tsr (CV5) failed to accumulate in either capillaries 
containing L-serine or AI-2, confirming the original finding that the Tsr receptor is nec-
essary to mediate AI-2 chemotaxis (Figure 12).  Further confirmation of earlier findings 
that LsrB is required for AI-2 chemotaxis was supplied by the failure of MJ101 (lsr-
BΩKanr) cells to accumulate in capillaries containing AI-2, although they maintained a 
normal response to L-serine (Figure 13).  Additionally, cells deleted for one of the mem-
brane-bound transporter proteins (lsrCΩKanr) maintained the ability to respond to both 
L-serine and AI-2 (Figure 13). 
The ability of tsr variants to mediate chemotaxis to AI-2.  To quantify AI-2 re-
sponse, and compare it to that of L-serine, capillary assays were again performed with 
the tsr variants generated from the docking model.  The plasmid bearing wild-type tsr set 
the standard for comparison, while the CV5 (∆tsr) strain served as the negative control.  
The point mutations were introduced into strain AS2002, and expression of the mutant 
proteins was induced with 100 µM IPTG.  Four of the point mutants, G144A, G146A, 
I148A and N149A (position 145 is an Ala), showed little to no variation in AI-2 re-
sponse, with dose response curves similar to that of the wild-type tsr.  The E150A point 
mutant was noticeably impaired for response to AI-2, though not to a significant degree.  
The K147A point mutant showed little to no accumulation in the capillary in the pres-






Figure 12.  Response of WT and variant cells to chemoattractant.  Shown are the normal-
ized values (buffer-only controls subtracted) of CV1 (WT), CV4 (Δtar) and CV5 (Δtsr) 
cells responding to capillaries containing either L-serine or AI-2.  Incubation of cells oc-
curred for 45 minutes at 30°C.  Trials were performed in triplicate with three biological 
replicates each.  Cells deleted for the Tsr chemoreceptor failed to respond significantly 
to either attractant.  Cells deleted for the Tar chemoreceptor responded to gradients of 








































Figure 13.  Response to chemoeffector by lsr operon variants.  Shown are normalized 
values of ∆lsrB (lsrBΩKanr) and ∆lsrC (lsrCΩKanr) cells responding to either L-serine 
or AI-2.  Cells were incubated at 30°C for 45 minutes.  Trials were performed in tripli-
cate for three biological replicates.  Cells lacking the AI-2 binding protein LsrB were 
unable to respond to a gradient of AI-2.  Cells lacking one of the AI-2 transport channel 





































the mutant proteins except for a 10% decrease with E150A (Figure 15).  Glu-150 is the 
residue closest to the serine-binding site. 
The amino acid residues Lys147 and Glu150 were selected for charge reversal 
point mutation to further investigate their importance.  The Ile148 residue was also se-
lected as a control since its dose response curve showed near wild-type level response in 
the alanine scanning mutant testing.  K147E, I148E and E150K were introduced sepa-
rately into AS2002 and tested in the capillary assay for response to L-serine and AI-2.  
The K147E variant showed a complete lack of response to AI-2.  The I148E variant re-
sponded with a near wild-type response curve, whereas the E150K variant gave a slight-
ly weaker response than its E150A counterpart – lower than the wild-type response but 
not significantly (Figure 16).  Again, serine response was not affected by these muta-
tions. 
The ability of lsrB variants in the N-terminal region (β-strand-2) to mediate 
chemotaxis to AI-2.  Capillaries assays were used to measure the chemotactic ability of 
lsrB variants to AI-2.  The docking model was again consulted to determine which ami-
no acid residues in the N-terminal region of LsrB should be subjected to alanine-
scanning mutagenesis.  The plasmid bearing wild-type LsrB was used as the standard for 
comparison for AI-2 chemotaxis.  MJ101 (lsrBΩKanr) was the negative control for 
chemotactic response to AI-2, showing no response in the assay.  Several alanine-
scanning variants in β-strand-2 showed little to no difference in dose response to AI-2 
from the capillary assay.  These included L56A, G57A, V58A, Y62A, G64A and P65A.  





Figure 14.  Tsr alanine-scanning mutant response to AI-2.  Background accumulations in 
buffer-only capillaries were between 7,000 and 15,000.  Shown are the normalized val-
ues (buffer-only controls subtracted) of CV5+pCA24N-tsr (AS2002), CV5 (Δtsr) and 
AS2002 tsr point mutant cells responding to capillaries containing AI-2.  Capillary as-
says were performed over a 45 minute incubation at 30°C in a slide warming chamber.  
Trials were performed in triplicate for three biological replicates.  Tsr variants were ex-
pressed from pCA24N with 100 µM IPTG induction.  The K147A variant accumulated 
only slightly more than the negative control.  Also reduced for AI-2 chemotaxis was the 










































Figure 15.  Tsr alanine-scanning mutant response to 10 mM L-serine.  Background ac-
cumulations in buffer-only capillaries were between 7,000 and 15,000.  Assays were car-
ried out in triplicate for three biological replicates.  Cells were incubated for 45 minutes 
at 30°C.  Variants were induced at 100 µM IPTG from plasmid pCA24N.  Capillary as-



























Figure 16.  Tsr charge reversal mutant response to AI-2.  Background accumulations in 
buffer-only capillaries were between 7,000 and 15,000.  Charge reversals of three select-
ed residues were carried out and variants were induced from plasmid pCA24N with 100 
μM IPTG.  K147E loses any ability to mediate AI-2 chemotaxis.  E150K response to AI-
2 is relatively unchanged from E150A.  Capillary assays were performed over a 45 mi-







































ination of the dose response to varying degrees in the V60A, T61A and D63A variants 
(Figure 17). 
The ability of lsrB variants in the C-terminal region (α-helix-8) to mediate chem-
otaxis to AI-2.  Amino acids in α-helix-8 of the LsrB C-terminus were subjected to ala-
nine-scanning mutagenesis based on the docking model.  These variant responses were 
again compared to the chemotactic response of wild-type LsrB expressed from plasmid 
pCA24N, and negative control MJ101.  Based on the results of these capillary assays, 
only the N249A mutant retained a wild-type dose response curve.  The R252A and 
E256A variants showed significantly altered response compared to wild-type, and the 
R252A/E256A double mutant failed to respond (Figure 18).  Charge reversal mutations 
were then introduced at these positions both singly and in a tandem.  Both the R252E 
and E256R variants showed a severe alteration in the AI-2 response compared to wild- 
type, with the double mutant (R252E/E256R) losing all ability to respond to AI-2 in the 
capillary assay (Figure 19). 
 Ability of LsrB variants to transport AI-2 in uptake assay.  Each of the LsrB vari-
ants was tested for its ability to participate in AI-2 uptake using the Vibrio harveyi TL26 
bioluminescence assay.  All variants in β-strand-2 showed a decrease in bioluminescence 
similar to wild-type LsrB between the 3 to 4 hour time points (Figure 20).  AI-2 uptake 
was not hindered in the D59A, V60A, T61A or D63A AI-2 chemotaxis mutants.  Like-
wise, variants in α-helix-8 were not hindered in their ability to transport AI-2 relative to 






Figure 17.  LsrB β-strand 2 variant response to AI-2.  Background accumulations in 
buffer-only capillaries were between 7,000 and 15,000.  Most variants retain a wild-type 
dose response curve.  Variants D59A, V60A, T61A and D63A, all show a drastically 
different dose response to a range of AI-2.  The D59A variant loses nearly all of its abil-
ity to respond to AI-2 via chemotaxis.  No induction was necessary as uninduced plas-
mid-born LsrB levels were similar to those of chromosomally produced LsrB.  Capillary 
assays were performed over a 45 minute incubation period at 30°C.  Trials were carried 














































Figure 18.  LsrB α-helix 8 variant response to AI-2.  Background accumulations in buff-
er-only capillaries were between 7,000 and 15,000.  Most variants retain a wild-type 
dose response curve.  Notable variants include R252A, E256A and the R252A/E256A 
double mutant, all of which show a lowered dose response to a range of AI-2.  No induc-
tion was necessary as uninduced plasmid-born LsrB levels were similar to those of 
chromosomally produced LsrB.  Capillary assays were performed over a 45 minute in-










































Figure 19.  LsrB α-helix 8 charge reversal variant response to AI-2.  Shown are the se-
lected point mutants that were subjected to charge reversal.  No induction from pCA24N 
was necessary since LsrB levels were similar to chromosomal levels.  Background ac-
cumulations ranged between 7,000 to 10,000 cells in buffer only.  Cells were incubated 
at 30°C for 45 minutes.  Trials were carried out in triplicate for three biological repli-
cates.  Charge reversal at R252 and E256 severely reduced AI-2 chemotaxis at higher 
concentrations and eliminated it at lower.  A charge reversal double mutant completely 








































Figure 20.  Ability of LsrB β-strand 2 variants to uptake AI-2.  Shown is the fold induc-
tion in luminescence in Vibrio harveyi TL26 following addition of E. coli supernatant 
from various growth time points.  Bioluminescence is measured in relative light units 
(RLU) and is defined as RLU of the sample / RLU of the culture medium.  All LsrB β-
strand 2 point mutants show the same reduction in luminescence profile as that observed 
with wild-type (~2 to 4 hours).  As a negative control, the ΔlsrB mutant continued to in-






























Figure 21.  Ability of LsrB α-helix 8 variants to uptake AI-2.  Shown is the fold induc-
tion in luminescence in Vibrio harveyi TL26 following addition of E. coli supernatant 
from various growth time points.  Bioluminescence is measured in relative light units 
(RLU) and is defined as RLU of the sample / RLU of the culture medium.  All LsrB α-
helix 8 point mutants show the same reduction in luminescence profile as that observed 
with wild-type (~2 to 4 hours).  As a negative control, the ∆lsrB mutant continued to in-
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any difference in uptake, with a delay of approximately one hour, though uptake still oc-
curred (Figure 22). 
Ability of key lsrB variants to respond to only exogenously sensed AI-2.  To en-
sure mutant response was to AI-2 sensed from the outside environment, plasmids carry-
ing key lsrB variants were transformed into cells deleted for the luxS gene.  LuxS is in-
volved in the production of AI-2 from S-adenosylhomocysteine, and deleting it removes 
the cell’s capability of producing any endogenous AI-2.  This serves the purpose of con-
firming that certain LsrB variants are not simply being overwhelmed by endogenously 
produced AI-2 within the cytoplasm and being sequestered away to give the negative 
chemotaxis result.  In a ∆luxS background, D59A, T61A, D63A and R252A showed no 
AI-2 chemotaxis improvement in the capillary assay when compared to strains carrying 
intact luxS.  Additionally, wild-type cells deleted for luxS were still able to mediate 
chemotaxis to AI-2 (Figure 23). 
Complementation of lsrB variants in a wild-type background.  In an attempt to 
determine if any of the LsrB variants deficient for AI-2 chemotaxis could be comple-
mented by the presence of wild-type protein, I transformed these variants into wild-type 
CV1 cells and tested their ability to respond to AI-2 in the capillary assay.  Protein levels 
of chromosomally-encoded and plasmid-encoded wild-type LsrB were already found to 
be nearly identical, so induction with IPTG was not necessary.  Interestingly, the dose 
response of the LsrB mutant D59A was not restored to wild-type level when the wild-
type LsrB protein was present (Figure 24).  The V60A variant dose response became 





Figure 22.  Ability of E.coli cells carrying an LsrB double mutant to uptake AI-2.  
Shown is the fold induction in luminescence in Vibrio harveyi TL26 following addition 
of E. coli supernatant from various growth time points.  Bioluminescence is measured in 
relative light units (RLU) and is defined as RLU of the sample / RLU of the culture me-
dium.  Both the T61/D63A and R252A/E256A double mutant show a delay in quenching 






























Figure 23.  AI-2 chemotaxis by LsrB variants in a ∆luxS background.  Key LsrB variants 
were expressed without induction from plasmid pCA24N in cells carrying a chromoso-
mal deletion for the luxS gene (strain AS2014).  Capillary assays were performed at 











































Figure 24.  AI-2 chemotaxis by LsrB variants in a CV1 background.  Key LsrB variants 
were expressed without induction from plasmid pCA24N in cells carrying a chromoso-
mal wild-type copy of LsrB.  Response to AI-2 gradients was rescued to some degree for 
most variants, with V60A being rescued to nearly wild-type levels.  Capillary assays 
were performed at 30°C for 45 minutes.  Each trial represents three biological replicates 







































in between.  These results suggest the D59A mutant may exhibit a dominant-negative 
phenotype, a condition not unlike that described in previous studies with MBP and Tar 
(122). 
Ability of pBAD-LsrB variants to mediate response to AI-2 gradients.  LsrB vari-
ants expressed under control of the PBAD promoter were exposed to serine and AI-2 gra-
dients in the capillary assay.  The accumulation of lsrB variant cells above background 
levels was within 97% of the response measured for those same over-expressed mutants 
carrying the C-terminal extension in pCA24N-lsrB (Figure 25).  There was no signifi-
cant variation in AI-2 response in the presence or absence of the C-terminal extension. 
 
Discussion 
 The docking of ligand-bound maltose binding protein (MBP) to Tar has been in-
vestigated extensively (105, 122, 125-127).   The resulting docking model has provided 
an excellent point of reference for our own proposed docking model of LsrB with Tsr.  
Because of the large degree of sequence and structural similarity between Tsr and Tar, 
orienting a binding protein for potential interaction with Tsr can be patterned somewhat 
after the MBP-Tar model.  Using this published model a proposed docking model for the 
interaction of ligand-bound LsrB and the periplasmic domain of Tsr was generated (Fig-
ure 10).  Residues of interest were highlighted for genetic analysis.  Figure 26 illustrates 
the location of the amino acid residues of interest in both the N-terminal and C-terminal 
regions of the ligand-bound conformation of LsrB.  Figure 11 indicates residues of par-






Figure 25.  Response to AI-2 by pBAD-lsrB variants.  Key LsrB variants were cloned 
into pBAD.  Mutants were induced with 0.2% arabinose for full induction.  Each key 
alanine substitution showed the same chemotaxis to AI-2 as it did when expressed from 
pCA24N.  Capillary assays were performed at 30°C for 45 minutes.  Each trial repre-















































Figure 26.  Structure of E. coli LsrB with residues of interest.  This structure of the LsrB 
binding protein is adapted from the published LsrB of Salmonella typhimurium (95).  
The β-strand 2 residues D53-P65 are highlighted in red in the N-terminus, while residues 
N249, R252 and E256 of α-helix 8 are highlighted in red in the C-terminus of the pro-
tein.  Each of these residues was chosen due to its proximity and likelihood of binding 




Alanine scanning mutagenesis of both proteins revealed particular amino acid residues 
that are critical for AI-2 chemotaxis to occur.  In Tsr the positively charged lysine at po-
sition 147 and negatively charged glutamate at position 150 must be present for E. coli 
cells to perform chemotaxis to AI-2.  Mutating these residues to alanine greatly depress-
es chemotaxis to AI-2, but has little effect on response to serine, leading us to conclude 
these alterations likely do not change the overall structure or function of the Tsr protein, 
only its ability to interact with LsrB and signal.  The fact that these are charged residues 
led us to surmise that electrostatic forces were likely at work during the interaction with 
LsrB.  I tested this theory by introducing charge reversals at these positions.  The result 
was a complete elimination of AI-2 response in cells carrying the K147E mutation, and a 
further attenuation of response in cells with the E150K mutation.  Reversing the charge 
at 147 likely resulted in electrostatic repulsion between the two proteins, causing the 
failure of the cells to respond to AI-2.  Because Tsr is a homodi- mer, lysine-147 is pre-
sent in both shoulder regions and likely serves as an anchoring point for the interaction 
with LsrB during chemotaxis. 
In LsrB the critical amino acids identified during the alanine-scanning mutagene-
sis were a mix of charged and non-polar residues.  Asp-59, Val-60, Thr-61, Asp-63, Arg-
252 and Glu-256 each seem to play a role in supporting chemotaxis to AI-2.  Changing 
each of these to Ala negatively affected AI-2 response to some degree, with D59A show-
ing the greatest deficiency.  The T61/D63 and R252A/E256 double mutants were re-
moved from consideration due to the delay they showed in transporting AI-2 into the 
cell.  This delay compared to wild-type is a likely indicator that these proteins either 
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couldn’t bind AI-2 well, or couldn’t interact with the LsrACD transport channel to im-
port AI-2.  Based on the location of the negatively charged aspartate residues (D59 and 
D63) in β-strand 2, they are likely candidates to electrostatically interact with the posi-
tively charged Lys-147 of Tsr on one homodimer shoulder.  In α-helix 8 is where the 
negatively charged Glu-256 possibly interacts with the other Lys-147 of the opposite 
shoulder in Tsr.  Due to their proximity, mutating the Val-60 and Thr-61 residues in β-
strand 2 of LsrB may affect the positioning of the Asp-59 and/or Asp-63 residues needed 
for interaction with Tsr.  Perhaps the alteration of these LsrB residues disrupts the tight 
interaction with Tsr, resulting in an inability to propagate a signal through transmem-
brane helix-2 of the chemoreceptor.  Additionally, the positively charged Arg-256 in α-
helix 8 may stabilize the LsrB-Tsr docking by interacting with the aforementioned Glu-
150 of Tsr.  These results lend credibility to our proposed docking model and elucidate 
the nature of the protein-protein interaction taking place during chemotaxis to AI-2. 
 Of obvious note is the wide range of expression levels detected in the LsrB mu-
tants expressed from pCA24N (data not shown).  While these results are curious, they 
likely do not affect AI-2 chemotaxis.  The fact that each of the LsrB mutants mentioned 
here maintains its ability to import AI-2 into the cell, according to the Vibrio harveyi bi-
oluminescence assay, indicates the reduction in AI-2 chemotaxis is not simply the result 
of altering the export and subsequent periplasmic concentration of LsrB with the C-
terminal extension.  In other words, they perform their native function at wild-type lev-
els, thus the mutations affect only chemotaxis.  This is further supported by the fact that 
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LsrB variants expressed from the pBAD plasmid respond to AI-2 at identical levels of 
those from the pCA24N plasmid. 
 While the protein expression levels are curious, it is certainly possible that AI-2 
chemotaxis is not directly correlated to LsrB expression in E. coli.  Further investigation 
into this issue will be discussed in Chapter V.  Overall, it appears that docking of LsrB to 
Tsr and signaling during AI-2 chemotaxis relies primarily on tight interaction with the 
N-terminal domain, specifically β-strand 2 of LsrB.  The C-terminal domain, specifically 
α-helix 8, likely serves to further stabilize the interaction and facilitate signaling. 
 Furthermore, the ability of the cells to produce their own AI-2 through the activi-
ty of LuxS doesn’t appear to affect their response to extracellular AI-2.  Key LsrB mu-
tants expressed in a LuxS deletion strain showed no variation in AI-2 response compared 
to strains with intact LuxS.  Production of AI-2 in the cytoplasm and its subsequent ex-
port apparently does not inhibit those cells from recognizing and responding to environ-
mental AI-2.  This may be due to the fact that by the time cells are producing enough AI-
2 themselves, the chemotaxis response to environmental AI-2 has already occurred. 
 Lastly, when attempts to complement mutant LsrB proteins with copies of wild-
type LsrB were made, the D59A and D63A variants failed to complement.  The reason 
for this is unclear, though perhaps they represent dominant negative phenotypes, where 
the mutant proteins are able to dock with Tsr but are unable to elicit signal propagation 
through the chemoreceptor.  If this is true, the interaction is still tight enough to block 
wild-type LsrB from complementing the mutation.  The investigation of these mutants 
will be further discussed in Chapter V. 
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CHAPTER III  
CORRELATING LSRB EXPRESSION LEVELS WITH AI-2 CHEMOTAXIS 
 
Introduction 
The expression of the periplasmic LsrB protein is regulated within the lsr operon 
of E. coli.  When population density is low, and a quorum sensing threshold of AI-2 is 
not achieved in the environment, the lsr operon is repressed by the LsrR protein.  Fol-
lowing sufficient addition of AI-2 to the local environment, this LsrR repression is re-
lieved by interaction with phosphorylated AI-2 (AI-2-P).  Thus, the operon produces 
LsrB, which in turn binds periplasmic AI-2 and transports it into the cytoplasm via the 
LsrACD transporter, resulting in the presence of more AI-2-P to relieve repression of the 
operon.  It is not until the last components of the operon (LsrFG) are made in sufficient 
quantities that AI-2-P is deconstructed and recycled, returning the operon to a repressed 
state (in concert with waning levels of environmental AI-2 presumably). 
As I have shown in the previous chapter, wild-type levels of chromosomal LsrB 
are sufficient to elicit a chemotaxis response to the R-THMF form of AI-2 in E. coli 
(Figure 12).  I wanted to determine (a) how much LsrB was produced in cells at various 
growth phases and its correlation to AI-2 chemotaxis, and (b) what affect stepwise in-
duction of LsrB expression from a plasmid had on the ability of the cells to perform 
chemotaxis to AI-2.  For the first question, cells were grown to increasing optical densi-
ties before protein levels and chemotaxis response were measured.   Log phase growth in 
E. coli is considered to begin when cells reach an O.D.600 just below 0.3; it progresses to 
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mid-logarithmic growth near 0.5; and enters late logarithmic growth between 0.7 and 
0.9.  During early log growth, cells would likely produce little AI-2, as the components 
of the lsr operon are not being highly expressed.  During mid-logarithmic growth, cells 
would begin expressing more of the LsrB binding proteins in order to transport AI-2 into 
the cells, leading to more expression of the lsr operon.  Once they reach later log growth, 
cells should have high amounts of AI-2 present. 
In the second scenario, an induction series was performed on plasmid-borne LsrB 
and response to AI-2 was measured in the capillary assay.  I found that increasing LsrB 
within the cells correlated negatively with AI-2 chemotaxis, though there was little effect 
on serine chemotaxis, and optimal response to AI-2 as a chemoattractant occurred during 
mid-log phase growth. 
Furthermore, I hypothesized that LsrB expression would change when different 
components of the lsr operon were independently deleted.  For instance, I expected more 
LsrB to be present when LsrR, the operon repressor, was deleted.  Conversely, I sur-
mised that deleting components of the ABC transporter LsrACD or the AI-2 degradation 
pathway LsrFG would have little to no effect on expression of LsrB.  I also tested the 
effect of deleting LuxS and TqsA on LsrB expression.  Likewise, I investigated whether 
deletions of these different genes affected chemotaxis to AI-2, and if these effects could 
be correlated to LsrB expression in these mutants.  Lastly, I tested effect on AI-2 chemo-
taxis in cells at various growth phases when the luxS gene was deleted.  Deletion of the 
LuxS enzyme ensures the cells are not producing endogenous AI-2, allowing us to ex-
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amine whether accumulation of endogenous AI-2 at earlier and later phases of growth 
influenced response to exogenous AI-2 added to the medium. 
I found there were few variations in LsrB expression in the individual deletion 
mutants.  I also found there was little to no difference in the AI-2 dose response curves 
of the individual deletion mutants, whether the component deleted was involved in syn-
thesis of AI-2, export of AI-2, or even import of AI-2.  Additionally, I saw a decrease in 
AI-2 response at later growth phases compared to mid-log phase growth, and observed 
strains carrying the luxS deletion varied little in chemotaxis response from their counter-
parts able to produce their own AI-2.  Overall, expression of LsrB did not seem to corre-
late to AI-2 chemotaxis. 
 
Materials and methods 
 Bacterial strains, plasmids and media.  Wild-type strain CV1 was used for the 
growth phase tests.  Deletion mutant strains were derived from CV1 using phage trans-
duction to disrupt target genes with a kanamycin resistance cassette before its removal as 
previously described (43).  Cassette was then removed by transforming cells with the 
pCP20 plasmid encoding an FLP recombinase (117).  The pCP20 plasmid was removed 
through a temperature-sensitive growth restriction and PCR was used to verify a clean 
gene deletion with removal of the kanamycin resistance cassette.  Table 2 lists the target 
genes deleted for use in this study.  IPTG-inducible plasmid pCA24N was employed to 
produce stepwise increases in LsrB expression in strain MJ101.  All strains were grown 
in tryptone broth media (10 g/L tryptone; 8 g/L NaCl) supplemented with antibiotic 
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where appropriate.  IPTG was added to inducible strains when optical density reached 
0.300 at wavelength 600 nm. 
 Measuring chemotaxis to AI-2 and serine at different growth phases.  Strain CV1 
was grown overnight in TB supplemented with streptomycin (50 µg/mL), then back-
diluted into four separate flasks to a turbidity of approximately 0.05 at O.D.600 in 25 mL 
tryptone broth without antibiotic.  Cells were then grown at 30°C with shaking to O.D600 
= 0.3, 0.5, 0.7 and 0.9 respectively.  All densities were either concentrated or diluted to 
O.D600 = 0.5 with chemotaxis buffer for uniform density upon addition to the cell reser-
voirs.  Motility was confirmed through microscopy.  Capillary assays (115) were used to 
quantify response to AI-2 and L-serine at the four different growth phases.  Centrifuga-
tion at 600 x g for 10 minutes separated the cell pellet from the growth media.  After re-
moval of the supernatant, cells were gently resuspended in an equal volume of chemo-
taxis buffer and given fifteen minutes of recovery time in a 30°C rotor.  Motility was 
again confirmed through microscopy before use in the capillary assay.  Cells were ex-
posed to gradients of 1 mM, 100 µM, 10 µM and 1 µM AI-2 in chemotaxis buffer. 
Measuring chemotaxis to attractants in the deletion strains.  Capillary assays 
(115) were chosen to quantify the chemotaxis responses to AI-2.  Overnight cultures of 
cells deleted for various AI-2 pathway genes were grown at 30°C in TB supplemented 
with streptomycin (50 µg/mL).  Cultures were back-diluted to a turbidity of ~0.05 at 
O.D.600 in 25 mL TB without antibiotic and grown to mid-logarithmic phase at an 
O.D.600 = ~0.5.  Cells were then centrifuged at 600 x g for 10 minutes to separate the soft 
pellet from the growth media.  The supernatant was removed and the pellet then gently 
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Table 2.  Bacterial strains and target genes for deletion studies 
Strain Target Gene Function 
   
Escherichia coli   
   
CV1a lsrA Kinase for LsrACD transporter 
   
 lsrB Periplasmic binding protein for AI-2 
   
 lsrC ABC transporter membrane channel 
protein 
   
 lsrD ABC transporter membrane channel 
protein 
   
 lsrF AI-2 degradation 
   
 lsrG AI-2 degradation 
   
 lsrK Kinase for phosphorylating AI-2 
   
 lsrR lsr operon repressor 
   
 luxS Synthesis of AI-2 precursor DPD 
   
 tqsA Export of AI-2 from the cell 
   
aKanamycin resistance cassettes were transduced to disrupt individual genes and then removed by FLP 
recombinase via temperature sensitive plasmid pCP20 (117).  Deletion of the gene of interest and removal 




resuspended in chemotaxis buffer as described previously.  The cells were given fifteen 
minutes of recovery time in a 30°C rotor set to low speed before use.  Motility of washed 
cells was confirmed through phase contrast microscopy before their addition to the cell 
reservoirs for exposure to attractant-laden capillaries. 
 Immunoblots for LsrB expression.  Whole cell protein preps were performed.  
Overnight cultures were diluted into 500 mL TB and grown at 30°C with shaking to 
O.D.600 = 0.5.   Cultures were centrifuged and the pellet was frozen at -80°C before be-
ing resuspended in 25 mL lysis buffer (5 mM DTT, 50 mM Tris (pH 8.0), 300 mM 
NaCl, 1 mM PMSF).  Resuspended pellets were then sonicated for 8 minutes (15 sec-
onds ON / 45 seconds OFF, 37% amplitude).  Centrifugation at ultra-high speed fol-
lowed before the supernatant was collected in lysis buffer.  This was then concentrated 
to 1 mL and quantified using the BCA assay.  Polyacrylamide gel electrophoresis was 
used with purified LsrB antibody to compare LsrB levels of growth phase variants and 
mutants to wild-type LsrB expressed from either the chromosome or the pCA24N plas-
mid. 
 IPTG induction series.  Strain CV1 with the lsrB deletion, carrying the pCA24N-
lsrB plasmid, was grown overnight in TB supplemented with chloramphenicol (35 µg/mL) to select for the plasmid.  The overnight was back-diluted into 25 mL of TB and 
grown at 30°C with shaking (250 rpm) to O.D.600 = 0.3.  At this point, varying concen-
trations of IPTG (purchased from Fisher Scientific) were added to the culture to induce 
lsrB expression.  Concentrations of IPTG used in the series included 0 µM, 1 µM, 10 µM, 100 µM and 1000 µM.  Cells were then returned to growth at 30°C until reaching an 
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O.D.600 of 0.5.  The cultures were then prepared for use in the capillary assay as de-
scribed previously, and capillary assays were performed to measure chemotaxis ability 
to AI-2.  Western blots were carried out as previously described to measure LsrB expres-
sion with regard to increasing concentrations of IPTG. 
 
Results 
 Growth phase effects on AI-2 chemotaxis in wild-type cells.  Growth of CV1 cells 
to varying phases showed obvious effects on AI-2 chemotaxis.  All growth phases 
(O.D.600 = 0.3, 0.5, 0.7 and 0.9) were tested at an O.D.600 = 0.5 for uniform testing in the 
capillary assay.  Because there is some evidence that E.coli cells begin to accumulate 
endogenously produced AI-2 in early log-phase growth (Sneha Jani, unpublished), I test-
ed from this point to late log phase growth.  At O.D.600 = 0.3 the dose response never 
saw an accumulation of more than 21,000 colony-forming units (CFUs) at any of the 
tested concentrations of AI-2.  This represented only 22% the response of cells at that 
same concentration during mid log phase growth, with the accumulation even lower at 
other points along the dose response curve.  Background accumulation of CFUs was also 
nearly 3 times lower at this growth phase compared to mid log, despite the densities be-
ing identical at the time of the assay.  At O.D.600 = 0.7, peak accumulation reached 
33,000 CFUs (1 mM AI-2), approximately 35% of the response at the same concentra-
tion in mid log phase.  At O.D.600 = 0.9 the maximum response was observed at 1 mM 
AI-2 and numbered 17,500 CFUs.  This was calculated to be 18% of the CFUs accumu-





Figure 27.  Response of log phase growth variants to AI-2 gradients.  Cells were grown 
to appropriate optical density, washed, and then resuspended in chemotaxis buffer to a 
final O.D.600 = 0.500.  Capillary assays were incubated at 30°C for 45 minutes, and data 




































 Growth phase effects on L-serine chemotaxis in wild-type cells.  Effects on 
chemotaxis to L-serine across the various growth phases tested were less extreme.  How-
ever, at O.D.600 = 0.3 the serine dose response curve was noticeably depressed compared 
to mid log phase (Figure 28).  Peak accumulation to serine at mid log phase occurred at 
1 mM (97,000 CFUs), but showed just 71,000 CFUs in cells grown to O.D.600 = 0.3, 
73% of the accumulation at 0.5.  The dose response curves for the remaining densities 
(0.7 and 0.9) were nearly identical to the mid log phase dose response curve (Figure 28). 
 Growth phase effects on AI-2 chemotaxis in ∆luxS cells.  When exposed to exog-
enous AI-2 in a ∆luxS background, early log phase cells (O.D.600 = 0.3) and late log 
phase cells (O.D.600 = 0.7 and 0.9) all showed peak accumulation at 1 mM, though none 
garnered much more than 30,000 CFUs, approximately one-third the response by mid 
log phase cells at the same concentration (Figure 29).  Response by these same growth 
phase variants to L-serine (Figure 30) generated a dose response curve nearly identical to 
that previously shown for wild-type cells. 
IPTG induction of pCA24N-lsrB and its effect on LsrB expression and AI-2 
chemotaxis.  CV1 (∆lsrB) was transformed with pCA24N-lsrB and induced with varying 
concentrations of IPTG.  Western blots indicated that the amount of LsrB produced var-
ied with increasing concentration of IPTG added during early log phase cell growth 
(Figure 31).  At 1 and 10 µM IPTG induction, the amount of LsrB was actually less than 
uninduced.  The increases in LsrB levels were significant at 100 µM IPTG, producing 
nearly 3 times that of uninduced.  At 1 mM IPTG, LsrB expression was approximately 6 





Figure 28.  Response of log phase growth variants to serine gradients.  Cells were grown 
to appropriate optical density, washed, then resuspended in chemotaxis buffer to a final 
O.D.600 = 0.500.  Peak accumulation occurred at 1 mM serine concentration.  At an ear-
lier stage of growth, E.coli CV1 cells responded at 73 % of the response at the same ser-
ine concentration along the dose response curve at mid log phase (0.500).  Later log 
stages of growth were at or near mid log phase dose response.  Capillary assays were 
incubated at 30°C for 45 minutes, and data points represent three biological replicates 







































Figure 29.  Response of ∆luxS log phase growth variants to AI-2 gradients.  Cells were 
grown to appropriate optical density, washed, then resuspended in chemotaxis buffer to a 
final O.D.600 = 0.500.  Peak accumulation occurred at 1 mM AI-2 concentration.  Capil-
lary assays were incubated at 30°C for 45 minutes, and data points represent three bio-











































Figure 30.  Response of ∆luxS log phase growth variants to serine gradients.  Cells were 
grown to appropriate optical density, washed, then resuspended in chemotaxis buffer to a 
final O.D.600 = 0.500.  Peak accumulation occurred at 1 mM serine concentration.  At an 
earlier stage of growth, cells responded at 73 % of the response at the same serine con-
centration along the dose response curve at mid log phase (0.500).  Later log stages of 
growth were at or near mid log phase dose response.  Capillary assays were incubated at 
30°C for 45 minutes, and data points represent three biological replicates with each con-






































Figure 31.  Western blots for IPTG induction of LsrB expression.  Plasmid pCA24N was 
used to express LsrB with varying amounts of IPTG induction during growth.  Induction 
ranged from 0 µM to 1000 µM IPTG, and whole cell extracts were prepared.  Samples 
were detected with anti-LsrB antibody and LsrB levels were calculated based on chemi-
luminescence intensity.  (a) Western blot image shows little LsrB production at 1 and 10 
µM IPTG induction, while bands are significantly darker for 100 and 1000 µM IPTG 
induction compared to uninduced samples from the same plasmid.  (b) LsrB levels rela-
tive to undinduced samples were estimated.  At 1 and 10 µM IPTG induction, LsrB lev-
els are less than 50 % of uninduced amount.  At 100 µM IPTG induction, there is ap-
proximately 3 time as much LsrB produced compared to uninduced.  At 1000 µM IPTG 





The chemotaxis assays for these inductions exhibited a negative correlation be-
tween amount of LsrB induced and ability of the cells to respond to AI-2 (Figure 32).  
The dose response curves were similar between the un-induced and 1 µM induction 
strains, though they shifted significantly beyond 1 µM induction.  Without induction, 
cells carrying plasmid-borne LsrB accumulated approximately 96,000 colony-forming 
units (CFUs) compared to approximately 95,000 CFUs of the 1µM induction strain at 1 
mM AI-2.  They decreased similarly along the same dose response curve with decreas-
ing AI-2 concentration.  The difference in dose response at 10 µM IPTG was significant-
ly lower, with no single accumulation garnering more than 78% of the un-induced value.  
The results were even more drastic at 100 µM and 1 mM IPTG induction, with no single 
response point for either garnering more than 33% and 4%, respectively, of un-induced 
response.  As a control, 100 mM L-serine was used in the capillary assay as well.  All of 
the induction strains accumulated CFUs of a similar number as the un-induced strain. 
 Effect of single gene knockouts on LsrB expression.  The LsrB gene product is 
the fourth gene in the lsr operon to be transcribed during expression, preceded by the 
components of the ABC transporter – LsrACD.  The expression of LsrB in the absence 
of both upstream and downstream flanking genes in the lsr operon was investigated.  
Figure 33 shows the relative LsrB protein levels in the various deletion mutant back-
grounds.  The amount of LsrB produced was noticeably higher than wild-type in the 
∆lsrR knockout and slightly lower in the ∆lsrK and ∆luxS knockouts. 





Figure 32.  IPTG induction series response to AI-2.  LsrB was expressed from pCA24N 
using various amounts of IPTG (0 to 1000 µM) during early log phase growth, then ex-
posed to AI-2 gradients after growth to mid log phase.  Serine response was not altered 







































Figure 33.  Expression of LsrB in select deletion mutants.  Strain CV1 was deleted for 
each of the components of the lsr operon, as well as genes involving AI-2 synthesis 
(luxS) and export (tqsA).  Western blots were performed on whole cell extracts of dele-
tion mutants using anti-LsrB antibody.  Most knockouts showed wild-type levels of 
LsrB.  Knockouts for lsrK and luxS showed reduced expression of LsrB relative to wild-
type.  Knockouts for lsrG and lsrR showed increased expression.  Deleting the repressor 




how the LsrB levels within the cell are affected when flanking lsr operon genes are de-
leted, I also tested the ability of these knockout mutants to perform AI-2 chemotaxis in 
the capillary assay.  The wild-type strain produced its maximum response at 1 mM AI-2, 
with 95,000 CFUs, then decreased to 86,000 CFUs at 100 µM, 66,000 CFUs at 10 µM 
and 6,000 at 1 µM.  Most of the deletion mutants in the primary transcription unit of the 
lsr operon (lsrACDBFG) produced similar dose response curves to AI-2 compared to 
wild-type E.coli (Figures 34 and 35).  Only the ∆lsrD strain showed a higher response at 
each point along the dose response curve compared to wild-type, yet even that increase 
was minimal at no more than 10%.  The other lsr operon transcription unit knockouts, 
consisting of ∆lsrR and ∆lsrK, along with both ∆luxS and ∆tqsA were observed for AI-2 
chemotaxis.  Only the ∆lsrK mutant deviated from wild-type along the dose response 
curve (Figure 35).  Though similar to wild-type with 92,000 CFUs at 1 mM AI-2, it 
dropped to approximately 84% of wild-type at 100 µM AI-2 and only 71% at 10 µM AI-
2 before bottoming out at 1 µM AI-2.  The ∆lsrR mutant actually showed slightly higher 
dose response than wild-type, though not significant at any point along the curve. 
 
Discussion 
 The expression of LsrB is regulated by the lsr operon and the presence of AI-2.  
When present at sufficient concentration in the periplasm, AI-2 is bound to LsrB which 
aids in importing AI-2 into the cytoplasm via the membrane transporter comprised of 
LsrA, LsrC and LsrD.  Once internalized, AI-2 is phosphorylated by the kinase LsrK.  It 





Figure 34.  Response to AI-2 by lsr operon knockouts.  Components of the lsrACDBFG 
operon were deleted individually in CV1, then tested for ability to respond to AI-2 gra-
dients.  All knockouts were able to perform chemotaxis at wild-type levels to AI-2, the 
exception being the lsrB deletion.  Capillary assays were performed at 30°C for 45 










































Figure 35.  Response to AI-2 by lsr-associated knockouts.  Regulatory genes lsrK and 
lsrR, as well as AI-2 synthesis protein LuxS and AI-2 exporter TqsA were deleted indi-
vidually in CV1, then tested for ability to respond to AI-2 gradients.  Capillary assays 
were performed at 30°C for 45 minutes.  Each trial represents three biological replicates 







































and LsrG are involved in breaking down phosphorylated AI-2 so it doesn’t accumulate 
to high levels in the cytoplasm.  Because of the feedback loop created by the presence of 
AI-2, altering any one of these components should have an effect on the levels of LsrB 
in the cell, and likewise the ability of the cells to respond to AI-2 gradients via chemo-
taxis. 
 Our approach to investigate the correlation between abundance of LsrB and 
chemotaxis response was three-fold.  First, I checked to see if cells naturally produce 
more LsrB by growing them to later log phase.  Our western blots for protein levels con-
firmed expression of LsrB increases with growth phase, with approximately 300 copies 
per cell present during mid logarithmic growth (S. Jani and M. Manson, unpublished), so 
I checked the chemotaxis ability of these growth variants in the capillary assay.  By 
growing wild-type cells to different densities and introducing them in the chemotaxis 
assays at a uniform density, I restricted the variables to growth phase rather than growth 
phase and density combined.  Contrary to our hypothesis, allowing more LsrB produc-
tion had a negative effect on chemotaxis to AI-2.  Optimal AI-2 response occurred at 
mid log phase and decreased significantly with later phases of growth.  I considered this 
may be due to the accumulation of endogenous AI-2 in the periplasm, so I repeated the 
assays with cells unable to produce their own AI-2 (∆luxS).  These cells would be ex-
posed only to exogenous AI-2.  The fact that these luxS mutants responded to the same 
degree as wild-type cells at each growth phase leads us to believe endogenous AI-2 does 
not contribute to the reduced chemotaxis response.  This lack of robust response could 
also be due to the fact that cells are less motile and less chemotactic during late log to 
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stationary phase as compared to mid log phase (128, 129).  Quantitative studies have al-
so shown that flagellar synthesis and mean run speed peak during mid log phase then 
decrease significantly as cells progress to late log and stationary phase (130).  In our par-
ticular strain (CV1) it has been observed that a roughly inverse relationship exists be-
tween run speed and tumble frequency during later stages of growth, and that it is more 
difficult to achieve full adaptation of a ligand-bound chemoreceptor during this 
timeframe (131).  Indeed, I found that response to L-serine was reduced as growth phase 
progressed.  A combination of these factors, in addition to various other global changes 
that occur as growth progresses, may make it difficult to accurately characterize chemo-
taxis at later stages of growth. 
 The second approach involved deleting components of the uptake and regulation 
pathway, including components of the transporter lsrACD and the kinase and repressor 
lsrK and lsrR, respectively.  This series also included luxS and TqsA, a membrane pro-
tein involved in export of newly synthesized AI-2 from the periplasm.  When protein 
levels of LsrB were measured through western blotting, the amount of LsrB in the ∆lsrR 
knockout was nearly six times the amount of expression as wild-type.  This did not dra-
matically increase the chemotaxis response to AI-2 in ∆lsrR, however, as its dose re-
sponse was nearly identical to wild-type.  On the other end of the expression spectrum, 
LsrB was expressed at only 20% of wild-type levels in ∆lsrK and only 10% of wild-type 
in ∆luxS.  Neither of these deficiencies appeared to affect AI-2 chemotaxis, however, as 
the dose response to AI-2 in these deletion mutants remained virtually identical to wild-
type, suggesting relatively few LsrB proteins can mediate a strong response to AI-2. 
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 A third approach involved inducing LsrB from a plasmid promoter.  Under PTAC 
control LsrB was overexpressed to a large degree, yet this had a negative impact on AI-2 
chemotaxis as measured in the capillary assay.  Western blots showed increasing levels 
of LsrB with increasing induction (with the exception of 1 and 10 µM IPTG induction), 
but with those increases came less chemotaxis to AI-2.  This was puzzling since the lim-
iting step of AI-2 chemotaxis seemed to be the amount of available LsrB to bind AI-2 
and interact with Tsr.  These results implied a negative correlation between amount of 
periplasmic LsrB and chemotaxis to AI-2.  It remains unclear why expression of LsrB 
actually decreased at lower levels of IPTG induction (1 and 10 µM) from the plasmid. 
 These results further solidify our hypothesis that optimal AI-2 chemotaxis occurs 
when LsrB copy level is at our just below 300 molecules per cell at mid log phase, and 
that the binding between Tsr and LsrB must be very tight to elicit such a strong response 
despite so few molecules present.  Further studies are required to fully understand the 
correlation between LsrB expression levels and chemotaxis to AI-2.  These ideas will be 
discussed in Chapter V. 
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CHAPTER IV  




 A mechanism for simultaneous sensing of two chemoeffectors by the same 
chemoreceptor has been described previously.  The Tar receptor can mediate chemotaxis 
to two independently binding ligands: L-aspartate and substrate-loaded maltose binding 
protein (MBP) (126).  Saturating concentrations of one ligand can and do affect response 
to the opposite ligand.  A more detailed analysis revealed that when forced to signal 
through the same Tar subunit, aspartate and maltose competed for signaling. 
Serine is a known, potent attractant for E.coli during chemotaxis.  Its receptor is 
one of the more abundant receptors present in the polar chemoreceptor signaling patches 
of E. coli cells (34).  The serine chemoreceptor (Tsr) binds L-serine directly at a known 
binding site consisting of a pocket formed by an arginine 69 residue on one Tsr mono-
mer and a threonine 156 on the other (107, 132, 133).  Sensing of AI-2 should not in-
volve these binding pockets and does not occur through direct ligand-binding.  Based on 
the docking model generated for the proposed interaction between ligand-bound LsrB 
and Tsr, AI-2 is sensed indirectly by Tsr through LsrB docking at its periplasmic shoul-
der regions. 
To ensure sensing of AI-2 does not in some way involve intact serine binding 
sites, I used the known binding site mutants to test the cells’ ability to respond to extra-
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cellular AI-2.  If the cells respond similar to wild-type, I surmise signaling for AI-2 nei-
ther involves direct sensing at the binding pockets, nor requires intact binding pockets 
comprised of Arg-69 and Thr-156 to transduce a response to AI-2. 
Using the Tar-MBP model as a starting point, I hypothesized that high concentra-
tions of one ligand could possibly affect the ability of the cells to respond to the other 
ligand in the capillary assay.  The serine chemoreceptor is one of the more abundant 
MCPs in E.coli cells, with Tar numbering nearly 15,000 at mid-log growth (34, 134), but 
those cells contain only about 300 copies of LsrB (S. Jani and M. Manson, unpublished) 
at mid-log phase growth.  Thus, I believed that high concentrations of AI-2 would have 
little effect on the ability of cells to respond to serine.  Conversely, I hypothesized that 
high concentrations of serine would render the cells blind to AI-2 gradients.  In other 
words, I looked for a shift near half maximal effective concentration (EC50) of response 
when the second ligand was present. 
 
Materials and methods 
 Bacterial strains, plasmids and media.  Strain CV1 was used as our wild-type 
strain.  Strain CV5 (∆Tsr) and CV1 (∆lsrB) were derived from CV1 as previously de-
scribed.  Plasmid pPA114, a relative of pKG116 (18, 135) carrying serine binding site 
mutations in tsr under sodium salicylate control, was used to express Tsr variants (136).  
The pPA114 plasmid was induced with 0.6 µM sodium salicylate.  All strains were 
grown in tryptone broth media (10 g/L tryptone; 8 g/L NaCl) supplemented with antibi-
otic where appropriate. 
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 Measuring chemotaxis to attractants by mutants for serine chemotaxis.  Capillary 
assays (114) were employed to quantify the ability of mutants for serine chemotaxis to 
respond to varying concentrations of AI-2.  Overnight cultures were grown at 30°C in 
TB supplemented with streptomycin (50 μg/mL) and chloramphenicol (30 µg/mL) for 
selection of the pPA114 plasmid.  Back dilutions were made to a turbidity of ~0.05 at 
O.D.600 in 25 mL TB without antibiotic.  Cells were grown to mid-logarithmic phase 
(O.D.600 = ~0.5) and centrifuged at 600 x g for 10 minutes to isolate them from the 
growth media.  Once the supernatant was removed, an equal volume of chemotaxis buff-
er was used to resuspend the cells.  They were given 15 minutes incubation at 30°C in a 
low speed test tube roller for recovery.  Motility was confirmed through direct observa-
tion with phase contrast microscopy. 
 Measuring chemotaxis to attractants in the presence of second ligand.  Capillary 
assays (115) were chosen to quantify the response to the chosen chemoattractant.  Over-
night cultures of cells were grown at 30°C in TB supplemented with streptomycin (50 µg/mL).  Cultures were back-diluted to a turbidity of ~0.05 at O.D.600 in 25 mL TB.  A 
100 µM concentration of the second ligand was also added to the growth media at this 
time.  When testing the response to AI-2 in the capillary assay, 100 μM L-serine was 
added; when testing for response to serine, 100 μM AI-2 was added.  Cells were then 
grown to mid-logarithmic phase at an O.D.600 = ~0.5.  Cells were then centrifuged at 600 
x g for 10 minutes to separate the cells from the media.  The supernatant was removed 
and the pellet gently resuspended in chemotaxis buffer containing 100 µM of the second 





Figure 36.  Response to L-serine by Tsr binding site knockout mutants.  Cells carrying 
substitutions at the major and minor serine binding sites of the Tsr receptor were ex-
posed to 10 mM L-serine and their response was measured in the capillary assay.  Mu-
tant Tsr proteins were expressed from sodium salicylate-inducible plasmid pPA114 
(136).  Capillary assays were performed at 30°C for 45 minutes.  Each trial represents 

































30°C rotor at low speed.  Motility of cells was then confirmed through phase contrast 
microscopy.  Second ligand was also added to dilutions of target ligand to ensure con-
stant exposure during the capillary assay. 
 
Results 
 Ability of cells mutated for serine binding site to respond to AI-2.  Previous ge-
netic studies have shown that mutations of the residues forming the serine-binding pock-
et between the Tsr subunits of its periplasmic domain negatively affect chemotaxis to L-
serine (137-139).  I confirmed this L-serine chemotaxis deficiency in the capillary assay.  
Cells carrying the R69E mutation (minor binding site) accumulated at less than 1% of 
the response by wild-type CV1 cells; cells carrying the T156K mutation (major binding 
site) showed only 3.5% wild-type response; binding pocket double mutants 
(R69E/T156K) accumulated to only 0.6% wild-type levels (Figure 36).  These binding 
pocket mutants, however, were not affected for chemotaxis to AI-2 (Figure 37).  Each of 
the mutants tested accumulated to within 97% or better of the wild-type dose response 
curve for AI-2 in the capillary assay.  Cells lacking either Tsr or LsrB failed to accumu-
late significantly to an AI-2 gradient. 
Effects of second ligand on response to target ligand.  When cells exposed to 
saturating concentrations of AI-2 during growth were exposed to L-serine in the capil-
lary assay, the dose response to serine (normalized to background control) was 105,000 
cells at 1 mM (92% serine only); 72,000 cells at 100 µM (85% serine only); 31,000 cells 






Figure 37.  Response to AI-2 by serine binding site mutants.  Mutations were selected 
based on previous findings of their affecting chemotaxis to serine.  Mutant Tsr proteins 
were expressed from sodium salicylate-inducible plasmid pPA114 (136).  Capillary as-
says were performed at 30°C for 45 minutes.  Each trial represents three biological repli-










































Figure 38.  Response to serine by cells grown with AI-2.  Wild-type CV1 cells were 
grown in the presence of 100 µM AI-2, then continuously exposed to this concentration 
of AI-2 during the capillary assay.  AI-2 was also present in the capillaries containing 
the L-serine concentrations for dose response.  Capillary assays were performed at 30°C 
































CV1 (100 uM AI-2)
 88 
 
background only control (saturating AI-2 present) averaged 9,500 cells accumulated, an 
amount similar to chemotaxis buffer lacking saturating ligand.  Response to AI-2 in the 
presence of saturating serine concentration (100 µM), again normalized to background, 
was quite different.  At 1 mM AI-2 exposure 43,000 cells accumulated (44% AI-2 only); 
at 100 µM exposure 7,000 cells accumulated (8% AI-2 only); at 10 µM exposure 1,500 
cells accumulated (2% AI-2 only); and at 1 µM exposure 800 cells accumulated (14% 
AI-2 only) (Figure 39).  Controls of background only (saturating L-serine present) aver-
aged 60,000 cells accumulated, whereas the background only response when no saturat-
ing chemoattractant was present averaged only 12,000 cells. 
 
Discussion 
 Each of the methyl accepting chemotaxis proteins (MCPs) of E. coli interact with 
a cognate binding protein carrying a particular ligand.  Some also sense ligands through 
direct binding interactions.  These interactions take place at the periplasmic region of the 
MCPs and the signal is transduced across the membrane to the distal tip of the chemore-
ceptor.  In cases where multiple ligands are recognized by a single chemoreceptor, as in 
the case with both aspartate and maltose in Tar, independent binding sites exist for the 
different ligands and have been genetically analyzed (41, 125). 
 Our recent work showed that AI-2 is sensed through E. coli Tsr with the aid of 
the AI-2 binding protein LsrB (Chapter II, Figures 8 and 13).  I surmised that the known 
ligands of Tsr utilize distinct binding sites of the receptor’s periplasmic domain.  I rea-





Figure 39.  Response to AI-2 by cells grown with serine.  Wild-type CV1 cells were 
grown in the presence of 100 µM L-serine, then continuously exposed to this concentra-
tion of serine during the capillary assay.  Serine was also present in the capillaries con-
taining the AI-2 concentrations for dose response tests.  Capillary assays were performed 
































CV1 (100 uM Ser)
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ability of the cells to respond to serine should not affect chemotaxis toward AI-2, or vice 
versa.  To elucidate this I tested for AI-2 chemotaxis in Tsr receptors that are unable to 
bind and respond to serine.  I already knew E. coli carrying Tsr mutations making them 
deficient for AI-2 chemotaxis were still able to respond to serine (Figure 15).  Quantify-
ing response to AI-2 in serine chemotaxis negative cells would allow us to quickly con-
firm this hypothesis. 
 Our results here support this hypothesis.  Mutations in the serine binding pockets 
of the Tsr homodimer, Arg-69 and Thr-156, did not affect response to varying concen-
trations of AI-2, as these mutants responded to this ligand just as well as wild-type.  This 
was not a surprise, however, as our docking model suggested AI-2 cannot directly bind 
to Tsr, and the binding protein LsrB interacts with Tsr at its periplasmic shoulder re-
gions. 
 A second approach involved exposing Tsr to hyper-physiological concentrations 
of one ligand prior to introducing the other.  Much as in the case of Tar with aspartate 
and maltose binding protein, I believed exposure to and binding of one ligand might pre-
clude binding and or response to the other.  Therefore, cells were grown in the presence 
of a high concentration of serine before use in chemotaxis assays, and serine was even 
added to the chemotaxis buffer solution to ensure constant exposure over the course of 
the assays.  The same was done using AI-2 as the second ligand.  Due to the abundance 
of Tsr in mid-logarithmic growth phase cells, and the relatively paltry amount of LsrB in 
comparison (roughly 300 molecules per cell) at this same growth phase, I hypothesized 
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response to serine would not be affected by the presence of AI-2, but that response to 
AI-2 gradients would be nearly impossible. 
 The results gathered here seem to support this specific hypothesis, though testing 
various background concentrations of the second ligand is necessary to make broader 
conclusions.  Response to serine was largely unaffected by the presence of exogenous 
AI-2, likely because at mid log phase cells produce an abundance of Tsr chemoreceptor 
in comparison to AI-2 binding proteins.  With so many receptors for serine and so few 
LsrB proteins present to bind the added AI-2, cells have little problem recognizing serine 
gradients and responding accordingly.  On the other hand, when serine is present at high 
concentrations it renders the E. coli cells blind to gradients of AI-2.  Even if all of the 
approximately 300 molecules of LsrB were loaded with AI-2, they would be unable to 
occupy all of the available Tsr receptors. 
 With so little LsrB present in wild-type cells, the window for response to AI-2 
appears to be very particular.  Perhaps overexpression of LsrB to levels closer to those of 
Tsr would allow for a level playing field in terms of opportunity for binding, although 
this does not align with our observations from Chapter III, where increasing levels of 
LsrB leads to decreased chemotaxis response to AI-2.  Further experiments along this 




CHAPTER V  
SUMMARY AND DISCUSSION 
 
Summary 
 Until recently, a periplasmic binding protein had not been identified for the Tsr 
chemoreceptor in E. coli.  The other MCPs (Tar, Tap, Trg) and the interactions with their 
cognate binding proteins have been studied extensively.  When the identification of a 
periplasmic binding protein for Tsr was proposed, a genetic analysis of the proposed in-
teraction, and a correlation between protein expression and chemotaxis became the goal 
of this thesis work.  In this dissertation I address the accuracy of the proposed docking 
model for the interaction between E.coli Tsr and AI-2-bound LsrB through site-directed 
mutagenesis, and I attempt to correlate chemotaxis to AI-2 with expression of LsrB and 
interference by the presence of a potential competing ligand. 
 The results from Chapter II suggest that the shoulder regions of the Tsr homodi-
mer, and residues in β-strand 2 and α-helix 8 of LsrB are critical for the interaction of 
Tsr and substrate-bound LsrB during AI-2 chemotaxis in E. coli.  The findings in Chap-
ter II support the proposed docking model developed and discussed in that chapter.  Re-
sults from Chapter III indicate that LsrB is present in low copy number (~300 molecules 
per cell) at mid log phase compared to the high-abundance chemoreceptors Tsr and Tar 
(~15,000 molecules per cell), and that overexpression of LsrB does not directly correlate 
to AI-2 chemotaxis.  Results here also showed that deleting various components of the 
lsr operon and production pathways, while slightly altering the expression levels of 
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LsrB, had little effect on AI-2 chemotaxis.  Only when the periplasmic binding protein 
for AI-2 (LsrB) was deleted was chemotaxis negatively affected.  Results from Chapter 
IV indicate that the presence of high concentrations of L-serine in the environment virtu-
ally blind the cells to the presence of AI-2, though the opposite is not true.  A high con-
centration of AI-2 does little to reduce chemotaxis to serine in mid-log phase cells.  
Here, it was also confirmed that the serine binding pockets of Tsr are not necessary for 
dose response to AI-2.  In this chapter, I discuss the likely mechanism of interaction be-
tween Tsr and LsrB, and explore the possible relationship between cellular levels of AI-
2, LsrB and chemotaxis.  I also suggest potential experiments to elucidate this relation-
ship, including biochemical studies involving investigation of binding affinity between 
Tsr and LsrB. 
 
Discussion 
A docking model for the Tsr-LsrB interaction.  A docking model for the interac-
tion between AI-2 bound LsrB and the Tar chemoreceptor was proposed and tested in 
Chapter II.  This model was based on the published model generated from studies of the 
Tar chemoreceptor and maltose binding protein (MBP), and an established experimental 
approach was available (105).  Single amino acid residues were shown to be vital for 
maltose chemotaxis to occur.  Mutation of these residues negatively affected response to 
maltose, presumably by disrupting the Tar-MBP interaction. 
The results in this chapter support our proposed docking model and identify key 
residues in both proteins that must be present for AI-2 chemotaxis to take place.  Alanine 
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substitutions in Tsr at Lys-147 and Glu-150 reduced AI-2 chemotaxis response in the 
capillary assay.  The Lys-147-Ala mutant lost nearly all ability to respond to AI-2 gradi-
ents.  The Glu-150-Ala mutant was significantly reduced for AI-2 chemotaxis, though it 
was nowhere near as depressed as the Lys-147-Ala mutant.  In LsrB alanine substitu-
tions at Asp-59, Val-60, Thr-61, Asp-63, Arg-252 and Glu-256 reduced AI-2 chemotaxis 
to varying degrees.  I will discuss the likely role of each of these residues in the Tsr-
LsrB interaction. 
Cells expressing the Tsr variant Lys-147-Ala failed to mediate more than 20% of 
the wild-type AI-2 chemotaxis response.  Lysine is a positively charged residue capable 
of forming a salt bridge with residues of the opposite charge in close proximity.  The 
docking model intimates a very tight coupling between Tsr and LsrB, conditions condu-
cive for electrostatic interactions to predominate.  Seeing as how the most critical resi-
dues in LsrB for AI-2 chemotaxis appear to be Asp-59 and Asp-63, positively charged 
amino acids, a salt bridge between Lys-147 in Tsr and Asp-59 or Asp-63 in LsrB is pos-
sibly a stabilizing force for this docking, and furthermore may be crucial for eliciting a 
signal after binding.  Because the Lys-147 is present in the other half of the Tsr ho-
modimer, this positive charge may also attract the Glu-256 of the LsrB C-terminal do-
main to form a second salt bridge, further stabilizing the interaction. 
The Glu-150 of Tsr potentially forms a salt bridge with the Arg-252 of the LsrB 
C-terminal domain, adding additional support to the interaction.  Taken together with the 
other likely salt bridges formed, the predominant stabilization forces behind the docking 
of Tsr to LsrB seem to be electrostatic.  When these forces are unperturbed, the two pro-
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teins could come together tightly enough to elicit a strong chemotaxis response despite a 
large disparity between the number of Tsr and LsrB molecules present in each cell.  
Such a tight interaction suggests a low dissociation constant and high affinity between 
Tsr and LsrB, much higher than the binding affinity of Tar for MBP.  Further biochemi-
cal studies are necessary to make firm conclusions in this area. 
The remaining residues of interest likely contribute to the overall stability of the 
binding.  The LsrB Thr-61, a polar residue, likely forms a supporting hydrogen bond 
with a residue in Tsr or a water molecule.  Water molecules have been shown to play 
roles in ligand-protein interaction.  Why the hydrophobic Val-60 in LsrB’s N-terminal 
domain is critical remains uncertain.  Substituting alanine for valine is simply swapping 
two hydrophobic amino acids, though valine is typically buried to a greater degree, and 
changing it to alanine possibly disrupts the conformation of LsrB enough to prohibit the 
Asp-59 to Lys-147 salt bridge from forming without affecting the affinity of LsrB for the 
LsrACD transport channel during AI-2 uptake. 
None of these critical single amino acid mutations affect the ability of LsrB to 
bind AI-2 in the periplasm and transport it back into the cell via the LsrACD transport 
apparatus.  Bioluminescent assays measuring AI-2 uptake in Vibrio harveyi show each 
of the point mutants perform AI-2 uptake along the same time frame as wild-type LsrB 
cells.  Therefore, I conclude these residues are critical for the Tsr-LsrB interaction, and 
play seemingly no role in normal lsr operon function.  These findings ensure the nega-




Additional mutations outside the proposed areas of interaction in LsrB and Tsr, 
and their effects on AI-2 chemotaxis, are needed as controls to support our docking 
model.  If mutations in areas of the proteins away from the interaction sites do not alter 
AI-2 chemotaxis, it would lend support to the nature of our proposed docking interac-
tion. 
The failure of wild-type LsrB to rescue the negative phenotype for AI-2 chemo-
taxis resulting from the Asp-59-Ala and Asp-63-Ala point mutations remains an interest-
ing result.  This finding of a potential dominant-negative phenotype requires further con-
sideration.  It may result from a stronger binding of this mutant LsrB with Tsr, preclud-
ing binding of wild-type LsrB to the chemoreceptor.  If this is the case, notably it does 
not seem to inhibit response to serine.  This scenario suggests the Asp-59 and Asp-63 
mutants are AI-2 signaling mutants rather than binding mutants.  A separate scenario for 
this effect may be dimerization of mutant and wild-type LsrB proteins, though AI-2 up-
take remained consistent with wild-type monomeric LsrB in the bioluminescence assay.  
Complementation studies in which residues in Tsr are mutated, beginning with Lys-147, 
could reverse this dominant negative phenotype to some degree.  Exchanging charges 
between Tsr and LsrB (Lys-147-Glu and Asp-59/63-Arg, respectively) could potentially 
counteract the disruption of salt bridge formation. 
A second possibility is that the LsrB protein could be locked into a closed con-
formation resulting from this point mutation.  While it is unlikely a surface mutation 
would have this effect, dominant negative phenotypes have been observed for maltose 
chemotaxis in E. coli and were the result of crosslinking event that locked MBP into its 
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substrate-free/closed conformation (140).  Perhaps introducing inter-domain cysteine-
cysteine crosslinks into wild-type LsrB could be used to test this.  If the dominant nega-
tive phenotype is the result of a closed conformation mutation, the dose response curve 
for this crosslinking mutant could look similar to the D59A or D63A mutants. 
The amount of LsrB present does not correlate directly with chemotaxis to AI-2.  
As mentioned in Chapter I, the expression of LsrB from the lsrACDBFG operon is regu-
lated by the presence of phosphorylated AI-2 (AI-2-P).  When a threshold of environ-
mental AI-2 is reached and it accumulates within the periplasm, it is imported into the 
cell via an ABC transporter.  Some amount of LsrB is present to bind the AI-2 and inter-
act with the LsrACD transport channel.  Once imported, AI-2 is phosphorylated by the 
kinase LsrK, at which point it can bind to LsrR and relieve repression of the lsr operon.  
When this occurs, more transport channel proteins are expressed (LsrACD) and more 
LsrB is produced, allowing more AI-2 to be taken into the cell.  Growing cells to later 
log phase allows up to six times as much LsrB to be present compared to the approxi-
mately 300 molecules per cell during mid logarithmic growth. 
Our initial hypothesis was that cells might respond to increasingly higher levels 
of AI-2 if more LsrB was available for binding and interacting with Tsr.  Not only was 
this assumption incorrect, the response actually decreased with increasing LsrB levels at 
later phase growth.  This result was confirmed with overexpression from an LsrB-
bearing plasmid.  To us, this suggests an optimal window for response to AI-2, namely 
at mid log phase cell growth and roughly 300 copies of LsrB per cell.  This suggests a 
scenario where E. coli cells growing and dividing in the gastrointestinal tract receive 
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quorum sensing information via AI-2 concentration and respond quickly, taking them to 
areas of higher cell density where nutrients may be more readily available, such as a 
pyre’s patch.  Once in these areas, the increasing levels of LsrB allow for import and 
degradation of AI-2 by the lsrFG gene products whose expression is also induced as re-
pression is relieved, thus returning the lsr operon to its pre AI-2 threshold state. 
Due to the numerous global changes occurring during later phase growth (128, 
130), it is difficult to make direct correlations between protein levels and chemotaxis 
response.  As cells move into later stages of the growth curve, swim speed and motility 
decrease in general, and frequency of tumbling increases.  Perhaps even the changing 
profile of the high abundance chemoreceptors Tsr and Tar at later log growth (141) 
makes chemotaxis to attractants, AI-2 among them, difficult to measure. 
Chemotaxis to AI-2 is reduced in the presence of serine.  Studies involving sim-
ultaneous exposure to gradients of L-aspartate and maltose for the E. coli Tar chemore-
ceptor have suggested a preference by cells for one attractant over another.  Under con-
ditions where the ligands were forced to bind and signal through the same Tar subunit, 
saturating concentrations of maltose only moderately inhibited aspartate chemotaxis, 
while the opposite showed a more drastic effect.  When saturating aspartate was present 
at the time the cells were exposed to maltose gradients, the response to maltose was vir-
tually eliminated (126).  The ligands were characterized as competing and aspartate was 
the winner.  This competition did not occur when ligands were forced into signaling 
through opposite subunits of Tar. 
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 My studies with background concentrations of serine and AI-2 have suggested 
these two ligands can signal through the same subunit as well.  Disrupting the binding 
pocket for serine at either Arg-69 or Thr-156 did not interfere with AI-2 chemotaxis.  
Likewise, mutants deficient in AI-2 chemotaxis still responded at wild-type levels to ser-
ine gradients.  When both attractants were present at the same time, however, the cells 
were unable to mount a dose response to AI-2.  When saturating levels of serine re-
mained constant throughout the exposure to AI-2, cells failed to perform any significant 
response to the latter in the capillary assay.  On the other hand, when AI-2 was the satu-
rating ligand at constant exposure, it did not reduce the chemotaxis response to serine 
relative to wild-type. 
 It is already apparent that LsrB is present at lower copy number per cell during 
mid logarithmic growth compared to Tsr, and this may be the central reason for the lack 
of response to AI-2 when serine is present.  If the cells have more opportunity to interact 
with serine due to the abundance of Tsr, they may become blind to AI-2 gradients at 
higher serine concentrations.  My results lean toward this conclusion.  With saturating 
AI-2 present, at 1 mM serine the response was within 93% of wild-type in the absence of 
competing ligand; at 100 µM serine the response fell to 85% of no competitor; and at 10 
µM serine it dropped to 63% of wild-type without AI-2 present (Figure 38).  This sug-
gests that only when levels of serine are low enough will cells begin to recognize the 
presence of AI-2 in the environment. 
 In the gastrointestinal tract of humans, E.coli does well to respond to serine as a 
priority to AI-2 since serine is a nutrient source for the cells.  Autoinducer-2 serves as a 
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signaling molecule, not a nutrient source; therefore, in this case it is in the cells’ best in-
terest to respond to a nutrient source over a non-nutrient source, especially considering 
that stable biofilms are not likely to appear in the dynamic gut.  Perhaps this is why so 
few copies of LsrB are present in the cells at a given time relative to Tsr or Tar.  When it 
serves the best interest of the cells to migrate away from low nutrient areas toward high-
er population densities – a potential indicator of plentiful nutrients –AI-2-laden LsrB has 
little competition for binding to Tsr and eliciting a chemotactic response.  Perhaps the 
grand balance of a healthy microbiome within the human gut is partially achieved 
through regulated response to nutrient sources and signaling molecules. 
 
Future Studies 
 My work here has provided a docking model for the interaction of AI-2-bound 
LsrB with Tsr during AI-2 chemotaxis in E. coli.  It has also shown there is no direct 
correlation between increasing levels of LsrB and chemotaxis to AI-2.  Furthermore, it 
has indicated that the presence of a high concentration of L-serine can reduce the ability 
of the cells to perform chemotaxis to AI-2.  However, there are certain aspects of AI-2 
chemotaxis that remain unanswered. 
 First, it can be determined whether serine and AI-2 compete to signal through the 
same subunit of Tsr.  Tsr can exist as a heterodimer of wild-type and mutant proteins 
when point mutants and wild-type versions of Tsr are expressed from compatible plas-
mids within the same cell.  These heterodimers will allow serine to bind in only one con-
formation, causing it to signal through a particular subunit.  If mutant LsrB proteins can 
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be forced to interact with Tsr and signal through that same subunit, it might be deter-
mined if serine and AI-2 signals compete for signaling.  This same scenario was studied 
with aspartate and MBP in Tar, and it was determined that when forced to signal through 
the same subunit of Tar, competition did occur (122). 
 Second, we can elucidate the effects of the presence of secondary attractants on 
response to either serine or AI-2.  Varied background concentrations of either serine or 
AI-2 would give a better picture of the amount of secondary ligand necessary to inhibit 
response to the first.  Up to this point, only 100 µM of either serine or AI-2 was used as 
background, but testing higher and lower concentrations would give us a better idea of 
the EC50 for each.  Furthermore on this point, expressing LsrB to levels higher than the 
300 copies produced by the chromosome at mid-log phase would clarify the ability of 
serine at 100 µM to reduce AI-2 chemotaxis.  By expressing extra LsrB from an induci-
ble plasmid, perhaps AI-2 chemotaxis would not be affected by the presence of serine.  
Even more useful would be the use of tethered cell assays or microfluidic assays that test 
the response of cells to multiple ligands in real time.  The capillary assay gives only a 
measure of the end result of exposure to chemoeffectors. 
Next, what roles do the aspartates in LsrB at positions 59 and 63 play during 
chemotaxis?  My results suggest both are critical to the ability of cells to respond to gra-
dients of AI-2.  It is unclear if they help stabilize the Tsr-LsrB interaction, or if they al-
low for signaling through Tsr to occur post-binding.  It would be useful to see the chem-
otaxis response of a D59A/D63A double mutant to determine if the charge or the posi-
tion is the important aspect. 
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Additionally, determining the binding affinity of LsrB for Tsr is important.  Due 
to its unstable nature, AI-2 has been an issue here.  According to our hypothesis, it must 
be present and bound to LsrB to get a closed conformation of LsrB that can interact with 
Tsr.  This is a problem for most biochemical assays that can help determine binding af-
finity.  It is also a problem for obtaining a co-crystal structure of LsrB-Tsr.  If we could 
obtain either a stable form of AI-2, or a closed conformation of LsrB that interacts with 
Tsr, it would make it possible to carry out the necessary biochemical assays for deter-
mining binding affinity and the nature of the interaction.  Assays such as isothermal ti-
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